Personalized Human Milk Proteome and Peptidome Profiling
Ordered by gene name. Choose Protein Accession, scroll for choices, or press backspace to type a search term
P04217%$#Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)%$#A1BG%$#TRUE%$#FALSE
P01023%$#Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)%$#A2M CPAMD5 FWP007%$#TRUE%$#FALSE
Q86V21%$#Acetoacetyl-CoA synthetase (EC 6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog)%$#AACS ACSF1%$#TRUE%$#FALSE
P61221%$#ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)%$#ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40%$#TRUE%$#FALSE
Q9UNQ0%$#ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)%$#ABCG2 ABCP BCRP BCRP1 MXR%$#TRUE%$#TRUE
Q96IU4%$#Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B)%$#ABHD14B CIB%$#TRUE%$#FALSE
Q8WTS1%$#1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58)%$#ABHD5 NCIE2 CGI-58%$#TRUE%$#FALSE
Q9P1F3%$#Costars family protein ABRACL (ABRA C-terminal-like protein)%$#ABRACL C6orf115 HSPC280 PRO2013%$#TRUE%$#FALSE
O00763%$#Acetyl-CoA carboxylase 2 (EC 6.4.1.2) (ACC-beta) [Includes: Biotin carboxylase (EC 6.3.4.14)]%$#ACACB ACC2 ACCB%$#TRUE%$#FALSE
Q9BWD1%$#Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)%$#ACAT2 ACTL%$#TRUE%$#FALSE
P12821%$#Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]%$#ACE DCP DCP1%$#TRUE%$#FALSE
P53396%$#ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)%$#ACLY%$#TRUE%$#FALSE
P21399%$#Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1)%$#ACO1 IREB1%$#TRUE%$#FALSE
O15254%$#Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)%$#ACOX3 BRCOX PRCOX%$#TRUE%$#FALSE
P33121%$#Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24)%$#ACSL1 FACL1 FACL2 LACS LACS1 LACS2%$#TRUE%$#TRUE
O95573%$#Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)%$#ACSL3 ACS3 FACL3 LACS3%$#TRUE%$#FALSE
O60488%$#Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)%$#ACSL4 ACS4 FACL4 LACS4%$#TRUE%$#FALSE
Q9NR19%$#Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)%$#ACSS2 ACAS2%$#TRUE%$#FALSE
P60709%$#Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]%$#ACTB%$#TRUE%$#TRUE
Q562R1%$#Beta-actin-like protein 2 (Kappa-actin)%$#ACTBL2%$#FALSE%$#TRUE
P68032%$#Actin, alpha cardiac muscle 1 (Alpha-cardiac actin) [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form]%$#ACTC1 ACTC%$#TRUE%$#FALSE
P63261%$#Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]%$#ACTG1 ACTG%$#TRUE%$#FALSE
P12814%$#Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)%$#ACTN1%$#TRUE%$#FALSE
O43707%$#Alpha-actinin-4 (Non-muscle alpha-actinin 4)%$#ACTN4%$#TRUE%$#FALSE
P61160%$#Actin-related protein 2 (Actin-like protein 2)%$#ACTR2 ARP2%$#TRUE%$#FALSE
P61158%$#Actin-related protein 3 (Actin-like protein 3)%$#ACTR3 ARP3%$#TRUE%$#FALSE
O14672%$#Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)%$#ADAM10 KUZ MADM%$#TRUE%$#FALSE
O15204%$#ADAM DEC1 (EC 3.4.24.-) (A disintegrin and metalloproteinase domain-like protein decysin-1) (ADAM-like protein decysin-1)%$#ADAMDEC1%$#TRUE%$#FALSE
Q9UHI8%$#A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1)%$#ADAMTS1 KIAA1346 METH1%$#TRUE%$#FALSE
O60266%$#Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)%$#ADCY3 KIAA0511%$#TRUE%$#TRUE
Q9Y653%$#Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)]%$#ADGRG1 GPR56 TM7LN4 TM7XN1 UNQ540/PRO1083%$#FALSE%$#TRUE
Q86SQ4%$#Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]%$#ADGRG6 DREG GPR126 VIGR%$#TRUE%$#FALSE
P30520%$#Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)%$#ADSS ADSS2%$#TRUE%$#FALSE
P43652%$#Afamin (Alpha-albumin) (Alpha-Alb)%$#AFM ALB2 ALBA%$#TRUE%$#FALSE
Q99943%$#1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15)%$#AGPAT1 G15%$#TRUE%$#FALSE
O00116%$#Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)%$#AGPS AAG5%$#TRUE%$#FALSE
O95994%$#Anterior gradient protein 2 homolog (AG-2) (hAG-2) (HPC8) (Secreted cement gland protein XAG-2 homolog)%$#AGR2 AG2 UNQ515/PRO1030%$#TRUE%$#FALSE
P01019%$#Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]%$#AGT SERPINA8%$#TRUE%$#FALSE
P23526%$#Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)%$#AHCY SAHH%$#TRUE%$#FALSE
Q96HN2%$#Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.3.1.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2)%$#AHCYL2 KIAA0828%$#TRUE%$#FALSE
P02765%$#Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]%$#AHSG FETUA PRO2743%$#TRUE%$#FALSE
Q9BQI0%$#Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2)%$#AIF1L C9orf58 IBA2 UNQ672/PRO1306%$#TRUE%$#FALSE
P00568%$#Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)%$#AK1%$#TRUE%$#FALSE
P14550%$#Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)%$#AKR1A1 ALDR1 ALR%$#TRUE%$#FALSE
P42330%$#Aldo-keto reductase family 1 member C3 (EC 1.-.-.-) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Indanol dehydrogenase) (EC 1.1.1.112) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20)%$#AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS%$#TRUE%$#FALSE
O43488%$#Aflatoxin B1 aldehyde reductase member 2 (EC 1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase)%$#AKR7A2 AFAR AFAR1 AKR7%$#TRUE%$#FALSE
P02768%$#Serum albumin%$#ALB GIG20 GIG42 PRO0903 PRO1708 PRO2044 PRO2619 PRO2675 UNQ696/PRO1341%$#TRUE%$#TRUE
P00352%$#Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic)%$#ALDH1A1 ALDC ALDH1 PUMB1%$#TRUE%$#FALSE
P47895%$#Aldehyde dehydrogenase family 1 member A3 (EC 1.2.1.36) (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3) (RALDH-3) (RalDH3)%$#ALDH1A3 ALDH6%$#TRUE%$#FALSE
O75891%$#Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)%$#ALDH1L1 FTHFD%$#TRUE%$#FALSE
P49419%$#Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)%$#ALDH7A1 ATQ1%$#TRUE%$#FALSE
P49189%$#4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABALDH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed]%$#ALDH9A1 ALDH4 ALDH7 ALDH9%$#TRUE%$#FALSE
P04075%$#Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)%$#ALDOA ALDA%$#TRUE%$#FALSE
P09972%$#Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)%$#ALDOC ALDC%$#TRUE%$#FALSE
Q86V81%$#THO complex subunit 4 (Tho4) (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF)%$#ALYREF ALY BEF THOC4%$#FALSE%$#TRUE
P02760%$#Protein AMBP [Cleaved into: Alpha-1-microglobulin (Protein HC) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin]%$#AMBP HCP ITIL%$#TRUE%$#FALSE
P04745%$#Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase)%$#AMY1A AMY1; AMY1B AMY1; AMY1C AMY1%$#TRUE%$#FALSE
P03950%$#Angiogenin (EC 3.1.27.-) (Ribonuclease 5) (RNase 5)%$#ANG RNASE5%$#TRUE%$#FALSE
Q9BY76%$#Angiopoietin-related protein 4 (Angiopoietin-like protein 4) (Hepatic fibrinogen/angiopoietin-related protein) (HFARP) [Cleaved into: ANGPTL4 N-terminal chain; ANGPTL4 C-terminal chain]%$#ANGPTL4 ARP4 HFARP PGAR PP1158 PSEC0166 UNQ171/PRO197%$#TRUE%$#FALSE
P15144%$#Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)%$#ANPEP APN CD13 PEPN%$#TRUE%$#FALSE
P04083%$#Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)%$#ANXA1 ANX1 LPC1%$#TRUE%$#TRUE
P50995%$#Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50)%$#ANXA11 ANX11%$#TRUE%$#FALSE
P07355%$#Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)%$#ANXA2 ANX2 ANX2L4 CAL1H LPC2D%$#TRUE%$#FALSE
P12429%$#Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)%$#ANXA3 ANX3%$#TRUE%$#FALSE
P09525%$#Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)%$#ANXA4 ANX4%$#TRUE%$#FALSE
P08758%$#Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)%$#ANXA5 ANX5 ENX2 PP4%$#TRUE%$#FALSE
P08133%$#Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70)%$#ANXA6 ANX6%$#TRUE%$#FALSE
P20073%$#Annexin A7 (Annexin VII) (Annexin-7) (Synexin)%$#ANXA7 ANX7 SNX OK/SW-cl.95%$#TRUE%$#FALSE
Q10567%$#AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)%$#AP1B1 ADTB1 BAM22 CLAPB2%$#TRUE%$#FALSE
P02743%$#Serum amyloid P-component (SAP) (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203)]%$#APCS PTX2%$#TRUE%$#FALSE
P13798%$#Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)%$#APEH D3F15S2 D3S48E DNF15S2%$#TRUE%$#FALSE
P27695%$#DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial]%$#APEX1 APE APE1 APEX APX HAP1 REF1%$#TRUE%$#FALSE
Q06481%$#Amyloid-like protein 2 (APLP-2) (APPH) (Amyloid protein homolog) (CDEI box-binding protein) (CDEBP)%$#APLP2 APPL2%$#TRUE%$#FALSE
Q9HDC9%$#Adipocyte plasma membrane-associated protein (Protein BSCv)%$#APMAP C20orf3 UNQ1869/PRO4305%$#TRUE%$#FALSE
P02647%$#Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]%$#APOA1%$#TRUE%$#TRUE
P02652%$#Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]%$#APOA2%$#TRUE%$#TRUE
P06727%$#Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4)%$#APOA4%$#TRUE%$#TRUE
P04114%$#Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]%$#APOB%$#TRUE%$#TRUE
P02654%$#Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]%$#APOC1%$#TRUE%$#FALSE
P02655%$#Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II (ProapoC-II)]%$#APOC2 APC2%$#TRUE%$#TRUE
P02656%$#Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3)%$#APOC3%$#TRUE%$#TRUE
P05090%$#Apolipoprotein D (Apo-D) (ApoD)%$#APOD%$#TRUE%$#FALSE
P02649%$#Apolipoprotein E (Apo-E)%$#APOE%$#TRUE%$#TRUE
Q13790%$#Apolipoprotein F (Apo-F) (Lipid transfer inhibitor protein) (LTIP)%$#APOF%$#TRUE%$#FALSE
P02749%$#Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI)%$#APOH B2G1%$#TRUE%$#FALSE
O14791%$#Apolipoprotein L1 (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I)%$#APOL1 APOL%$#TRUE%$#FALSE
O95445%$#Apolipoprotein M (Apo-M) (ApoM) (Protein G3a)%$#APOM G3A NG20 HSPC336%$#TRUE%$#FALSE
P05067%$#Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]%$#APP A4 AD1%$#TRUE%$#FALSE
Q9UKG1%$#DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)%$#APPL1 APPL DIP13A KIAA1428%$#TRUE%$#FALSE
P07741%$#Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)%$#APRT%$#TRUE%$#FALSE
P48444%$#Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP)%$#ARCN1 COPD%$#TRUE%$#FALSE
P61204%$#ADP-ribosylation factor 3%$#ARF3%$#TRUE%$#FALSE
P18085%$#ADP-ribosylation factor 4%$#ARF4 ARF2%$#TRUE%$#FALSE
P84085%$#ADP-ribosylation factor 5%$#ARF5%$#TRUE%$#FALSE
P62330%$#ADP-ribosylation factor 6%$#ARF6%$#TRUE%$#FALSE
Q07960%$#Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP)%$#ARHGAP1 CDC42GAP RHOGAP1%$#FALSE%$#TRUE
Q8N392%$#Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18)%$#ARHGAP18%$#TRUE%$#FALSE
P52565%$#Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)%$#ARHGDIA GDIA1%$#TRUE%$#FALSE
P52566%$#Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Ly-GDI) (Rho-GDI beta)%$#ARHGDIB GDIA2 GDID4 RAP1GN1%$#TRUE%$#TRUE
Q9NXU5%$#ADP-ribosylation factor-like protein 15 (ADP-ribosylation factor-related protein 2) (ARF-related protein 2)%$#ARL15 ARFRP2%$#TRUE%$#FALSE
Q15041%$#ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Apoptotic regulator in the membrane of the endoplasmic reticulum)%$#ARL6IP1 ARL6IP ARMER KIAA0069%$#TRUE%$#FALSE
O75915%$#PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27)%$#ARL6IP5 DERP11 JWA PRA2 PRAF3 HSPC127%$#TRUE%$#TRUE
O15143%$#Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)%$#ARPC1B ARC41%$#TRUE%$#FALSE
O15144%$#Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)%$#ARPC2 ARC34 PRO2446%$#TRUE%$#FALSE
O15145%$#Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)%$#ARPC3 ARC21%$#TRUE%$#FALSE
P59998%$#Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)%$#ARPC4 ARC20%$#TRUE%$#FALSE
O15511%$#Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC)%$#ARPC5 ARC16%$#TRUE%$#FALSE
Q9BPX5%$#Actin-related protein 2/3 complex subunit 5-like protein (Arp2/3 complex 16 kDa subunit 2) (ARC16-2)%$#ARPC5L%$#TRUE%$#FALSE
P49407%$#Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2)%$#ARRB1 ARR1%$#TRUE%$#FALSE
Q13510%$#Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein) (PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]%$#ASAH1 ASAH HSD-33 HSD33%$#TRUE%$#FALSE
P04424%$#Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)%$#ASL%$#TRUE%$#FALSE
Q12797%$#Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)%$#ASPH BAH%$#TRUE%$#FALSE
P00966%$#Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)%$#ASS1 ASS%$#TRUE%$#FALSE
Q6DD88%$#Atlastin-3 (EC 3.6.5.-)%$#ATL3%$#TRUE%$#FALSE
Q4VNC1%$#Probable cation-transporting ATPase 13A4 (EC 3.6.3.-) (P5-ATPase isoform 4)%$#ATP13A4 UNQ3052/PRO9871%$#TRUE%$#FALSE
Q01814%$#Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2)%$#ATP2B2 PMCA2%$#TRUE%$#TRUE
P25705%$#ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)%$#ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM%$#TRUE%$#FALSE
P06576%$#ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)%$#ATP5F1B ATP5B ATPMB ATPSB%$#TRUE%$#FALSE
O75964%$#ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)%$#ATP5MG ATP5L%$#TRUE%$#FALSE
O75947%$#ATP synthase subunit d, mitochondrial (ATPase subunit d) (ATP synthase peripheral stalk subunit d)%$#ATP5PD ATP5H My032%$#TRUE%$#FALSE
Q15904%$#V-type proton ATPase subunit S1 (V-ATPase subunit S1) (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)%$#ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3%$#TRUE%$#TRUE
O75787%$#Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adaptor) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit)%$#ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072%$#TRUE%$#FALSE
P61421%$#V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (32 kDa accessory protein) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit) (p39) (Vacuolar proton pump subunit d 1)%$#ATP6V0D1 ATP6D VPATPD%$#TRUE%$#FALSE
P38606%$#V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha)%$#ATP6V1A ATP6A1 ATP6V1A1 VPP2%$#TRUE%$#FALSE
P21281%$#V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)%$#ATP6V1B2 ATP6B2 VPP3%$#TRUE%$#FALSE
Q9Y5K8%$#V-type proton ATPase subunit D (V-ATPase subunit D) (V-ATPase 28 kDa accessory protein) (Vacuolar proton pump subunit D)%$#ATP6V1D ATP6M VATD%$#FALSE%$#TRUE
O75348%$#V-type proton ATPase subunit G 1 (V-ATPase subunit G 1) (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16)%$#ATP6V1G1 ATP6G ATP6G1 ATP6J%$#TRUE%$#FALSE
O75882%$#Attractin (DPPT-L) (Mahogany homolog)%$#ATRN KIAA0548 MGCA%$#TRUE%$#FALSE
Q9Y679%$#Ancient ubiquitous protein 1%$#AUP1%$#TRUE%$#FALSE
P25311%$#Zinc-alpha-2-glycoprotein (Zn-alpha-2-GP) (Zn-alpha-2-glycoprotein)%$#AZGP1 ZAG ZNGP1%$#TRUE%$#FALSE
P20160%$#Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP)%$#AZU1%$#TRUE%$#FALSE
P61769%$#Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]%$#B2M CDABP0092 HDCMA22P%$#TRUE%$#TRUE
Q9Y2A9%$#N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 (EC 2.4.1.149) (Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase) (EC 2.4.1.146) (Beta-1,3-galactosyltransferase 8) (Beta-1,3-GalTase 8) (Beta3Gal-T8) (Beta3GalT8) (b3Gal-T8) (Beta-3-Gx-T8) (Core 1 extending beta-1,3-N-acetylglucosaminyltransferase) (Core1-beta3GlcNAcT) (Transmembrane protein 3) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3) (BGnT-3) (Beta-1,3-Gn-T3) (Beta-1,3-N-acetylglucosaminyltransferase 3) (Beta3Gn-T3) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8)%$#B3GNT3 B3GALT8 TMEM3 UNQ637/PRO1266%$#TRUE%$#FALSE
P15291%$#Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]%$#B4GALT1 GGTB2%$#TRUE%$#TRUE
Q9UQB8%$#Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53)%$#BAIAP2%$#TRUE%$#FALSE
P80723%$#Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22)%$#BASP1 NAP22%$#TRUE%$#TRUE
P51572%$#B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28)%$#BCAP31 BAP31 DXS1357E%$#TRUE%$#FALSE
P55957%$#BH3-interacting domain death agonist (p22 BID) (BID) [Cleaved into: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)]%$#BID%$#TRUE%$#FALSE
Q9UBW5%$#Bridging integrator 2 (Breast cancer-associated protein 1)%$#BIN2 BRAP1%$#FALSE%$#TRUE
P30043%$#Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)%$#BLVRB FLR%$#TRUE%$#FALSE
P13497%$#Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP)%$#BMP1 PCOLC%$#TRUE%$#FALSE
P17213%$#Bactericidal permeability-increasing protein (BPI) (CAP 57)%$#BPI%$#TRUE%$#FALSE
Q5VW32%$#BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)%$#BROX BROFTI C1orf58%$#TRUE%$#FALSE
Q96G97%$#Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein)%$#BSCL2%$#TRUE%$#FALSE
P35613%$#Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)%$#BSG UNQ6505/PRO21383%$#TRUE%$#FALSE
Q10588%$#ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (EC 3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPr hydrolase 2) (CD antigen CD157)%$#BST1%$#TRUE%$#FALSE
Q10589%$#Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317)%$#BST2%$#TRUE%$#FALSE
P43251%$#Biotinidase (Biotinase) (EC 3.5.1.12)%$#BTD%$#TRUE%$#FALSE
P20290%$#Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3)%$#BTF3 NACB OK/SW-cl.8%$#FALSE%$#TRUE
Q13410%$#Butyrophilin subfamily 1 member A1 (BT)%$#BTN1A1 BTN%$#TRUE%$#TRUE
O00478%$#Butyrophilin subfamily 3 member A3%$#BTN3A3 BTF3%$#TRUE%$#FALSE
Q6UX73%$#UPF0764 protein C16orf89%$#C16orf89 UNQ904/PRO1925%$#TRUE%$#FALSE
Q96EU7%$#C1GALT1-specific chaperone 1 (C38H2-like protein 1) (C38H2-L1) (Core 1 beta1,3-galactosyltransferase 2) (C1Gal-T2) (C1GalT2) (Core 1 beta3-Gal-T2) (Core 1 beta3-galactosyltransferase-specific molecular chaperone)%$#C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310%$#TRUE%$#FALSE
Q9BXJ1%$#Complement C1q tumor necrosis factor-related protein 1 (G protein-coupled receptor-interacting protein) (GIP)%$#C1QTNF1 CTRP1 UNQ310/PRO353%$#TRUE%$#FALSE
Q9NZP8%$#Complement C1r subcomponent-like protein (C1r-LP) (C1r-like protein) (EC 3.4.21.-) (C1r-like serine protease analog protein) (CLSPa)%$#C1RL C1RL1 C1RLP CLSPA%$#TRUE%$#FALSE
P09871%$#Complement C1s subcomponent (EC 3.4.21.42) (C1 esterase) (Complement component 1 subcomponent s) [Cleaved into: Complement C1s subcomponent heavy chain; Complement C1s subcomponent light chain]%$#C1S%$#TRUE%$#FALSE
P06681%$#Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]%$#C2%$#TRUE%$#FALSE
P01024%$#Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]%$#C3 CPAMD1%$#TRUE%$#TRUE
P0C0L4%$#Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]%$#C4A CO4 CPAMD2%$#TRUE%$#TRUE
P0C0L5%$#Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]%$#C4B CO4 CPAMD3; C4B_2%$#TRUE%$#FALSE
P04003%$#C4b-binding protein alpha chain (C4bp) (Proline-rich protein) (PRP)%$#C4BPA C4BP%$#TRUE%$#FALSE
P01031%$#Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]%$#C5 CPAMD4%$#TRUE%$#FALSE
P13671%$#Complement component C6%$#C6%$#TRUE%$#FALSE
Q6UXA7%$#Uncharacterized protein C6orf15 (Protein STG)%$#C6orf15 STG UNQ1840/PRO3566%$#FALSE%$#TRUE
P10643%$#Complement component C7%$#C7%$#TRUE%$#FALSE
P07357%$#Complement component C8 alpha chain (Complement component 8 subunit alpha)%$#C8A%$#TRUE%$#FALSE
P07358%$#Complement component C8 beta chain (Complement component 8 subunit beta)%$#C8B%$#TRUE%$#FALSE
P07360%$#Complement component C8 gamma chain%$#C8G%$#TRUE%$#FALSE
P02748%$#Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b]%$#C9%$#TRUE%$#FALSE
P00918%$#Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II)%$#CA2%$#TRUE%$#FALSE
P23280%$#Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)%$#CA6%$#TRUE%$#FALSE
Q9Y376%$#Calcium-binding protein 39 (MO25alpha) (Protein Mo25)%$#CAB39 MO25 CGI-66%$#TRUE%$#FALSE
P54289%$#Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1]%$#CACNA2D1 CACNL2A CCHL2A MHS3%$#TRUE%$#FALSE
Q9HB71%$#Calcyclin-binding protein (CacyBP) (hCacyBP) (S100A6-binding protein) (Siah-interacting protein)%$#CACYBP S100A6BP SIP PNAS-107%$#TRUE%$#FALSE
P22676%$#Calretinin (CR) (29 kDa calbindin)%$#CALB2 CAB29%$#TRUE%$#FALSE
P27797%$#Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60)%$#CALR CRTC%$#TRUE%$#FALSE
O43852%$#Calumenin (Crocalbin) (IEF SSP 9302)%$#CALU%$#TRUE%$#FALSE
P49913%$#Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37]%$#CAMP CAP18 FALL39 HSD26%$#TRUE%$#FALSE
Q86VP6%$#Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1)%$#CAND1 KIAA0829 TIP120 TIP120A%$#TRUE%$#FALSE
Q8WVQ1%$#Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)%$#CANT1 SHAPY%$#TRUE%$#FALSE
P27824%$#Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90)%$#CANX%$#TRUE%$#TRUE
Q01518%$#Adenylyl cyclase-associated protein 1 (CAP 1)%$#CAP1 CAP%$#TRUE%$#FALSE
P40121%$#Macrophage-capping protein (Actin regulatory protein CAP-G)%$#CAPG AFCP MCP%$#TRUE%$#FALSE
P07384%$#Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP)%$#CAPN1 CANPL1 PIG30%$#TRUE%$#FALSE
P04632%$#Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit)%$#CAPNS1 CAPN4 CAPNS%$#TRUE%$#FALSE
P52907%$#F-actin-capping protein subunit alpha-1 (CapZ alpha-1)%$#CAPZA1%$#TRUE%$#FALSE
P47755%$#F-actin-capping protein subunit alpha-2 (CapZ alpha-2)%$#CAPZA2%$#TRUE%$#FALSE
P47756%$#F-actin-capping protein subunit beta (CapZ beta)%$#CAPZB%$#TRUE%$#FALSE
P04040%$#Catalase (EC 1.11.1.6)%$#CAT%$#TRUE%$#FALSE
P16152%$#Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)%$#CBR1 CBR CRN SDR21C1%$#TRUE%$#FALSE
P0DN79%$#Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)%$#CBSL%$#TRUE%$#FALSE
Q9NRJ3%$#C-C motif chemokine 28 (Mucosae-associated epithelial chemokine) (MEC) (Protein CCK1) (Small-inducible cytokine A28)%$#CCL28 SCYA28%$#TRUE%$#FALSE
P78371%$#T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)%$#CCT2 99D8.1 CCTB%$#TRUE%$#FALSE
P49368%$#T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)%$#CCT3 CCTG TRIC5%$#TRUE%$#FALSE
P50991%$#T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)%$#CCT4 CCTD SRB%$#TRUE%$#FALSE
P48643%$#T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)%$#CCT5 CCTE KIAA0098%$#TRUE%$#FALSE
P40227%$#T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)%$#CCT6A CCT6 CCTZ%$#TRUE%$#FALSE
Q99832%$#T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]%$#CCT7 CCTH NIP7-1%$#TRUE%$#FALSE
P50990%$#T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)%$#CCT8 C21orf112 CCTQ KIAA0002%$#TRUE%$#FALSE
P08571%$#Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form]%$#CD14%$#TRUE%$#TRUE
P20138%$#Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33)%$#CD33 SIGLEC3%$#FALSE%$#TRUE
P16671%$#Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36)%$#CD36 GP3B GP4%$#TRUE%$#FALSE
Q08722%$#Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47)%$#CD47 MER6%$#TRUE%$#FALSE
P08174%$#Complement decay-accelerating factor (CD antigen CD55)%$#CD55 CR DAF%$#TRUE%$#FALSE
P13987%$#CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59)%$#CD59 MIC11 MIN1 MIN2 MIN3 MSK21%$#TRUE%$#FALSE
O43866%$#CD5 antigen-like (Apoptosis inhibitor expressed by macrophages) (hAIM) (CT-2) (IgM-associated peptide) (SP-alpha)%$#CD5L API6 UNQ203/PRO229%$#TRUE%$#FALSE
P08962%$#CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63)%$#CD63 MLA1 TSPAN30%$#TRUE%$#FALSE
P04233%$#HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (p33) (CD antigen CD74)%$#CD74 DHLAG%$#TRUE%$#FALSE
P60033%$#CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81)%$#CD81 TAPA1 TSPAN28%$#TRUE%$#TRUE
P27701%$#CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82)%$#CD82 KAI1 SAR2 ST6 TSPAN27%$#TRUE%$#FALSE
P21926%$#CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9)%$#CD9 MIC3 TSPAN29 GIG2%$#TRUE%$#FALSE
P32320%$#Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)%$#CDA CDD%$#TRUE%$#FALSE
Q16543%$#Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]%$#CDC37 CDC37A%$#TRUE%$#FALSE
P60953%$#Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein)%$#CDC42%$#TRUE%$#FALSE
P12830%$#Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3]%$#CDH1 CDHE UVO%$#TRUE%$#TRUE
Q96JB5%$#CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27)%$#CDK5RAP3 IC53 LZAP MSTP016 OK/SW-cl.114 PP1553%$#TRUE%$#FALSE
P13688%$#Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a)%$#CEACAM1 BGP BGP1%$#TRUE%$#FALSE
P31997%$#Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)%$#CEACAM8 CGM6%$#TRUE%$#FALSE
P19835%$#Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Bucelipase) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase)%$#CEL BAL%$#TRUE%$#TRUE
Q6UWW8%$#Carboxylesterase 3 (EC 3.1.1.1) (Liver carboxylesterase 31 homolog)%$#CES3 UNQ869/PRO1887%$#TRUE%$#TRUE
Q5XG92%$#Carboxylesterase 4A (EC 3.1.1.-)%$#CES4A CES8 UNQ440/PRO873%$#TRUE%$#FALSE
P00751%$#Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]%$#CFB BF BFD%$#TRUE%$#TRUE
P08603%$#Complement factor H (H factor 1)%$#CFH HF HF1 HF2%$#TRUE%$#FALSE
Q03591%$#Complement factor H-related protein 1 (FHR-1) (H factor-like protein 1) (H-factor-like 1) (H36)%$#CFHR1 CFHL CFHL1 CFHL1P CFHR1P FHR1 HFL1 HFL2%$#TRUE%$#FALSE
P36980%$#Complement factor H-related protein 2 (FHR-2) (DDESK59) (H factor-like 3) (H factor-like protein 2)%$#CFHR2 CFHL2 FHR2 HFL3%$#TRUE%$#FALSE
P05156%$#Complement factor I (EC 3.4.21.45) (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain]%$#CFI IF%$#TRUE%$#FALSE
P23528%$#Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)%$#CFL1 CFL%$#TRUE%$#TRUE
P27918%$#Properdin (Complement factor P)%$#CFP PFC%$#TRUE%$#FALSE
P36222%$#Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39) (CGP-39) (GP-39) (hCGP-39) (YKL-40)%$#CHI3L1%$#TRUE%$#FALSE
Q15782%$#Chitinase-3-like protein 2 (Chondrocyte protein 39) (YKL-39)%$#CHI3L2%$#TRUE%$#FALSE
Q9BWS9%$#Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein) (SI-CLP)%$#CHID1 GL008 PSEC0104 SB139%$#TRUE%$#FALSE
O43633%$#Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1)%$#CHMP2A BC2 CHMP2%$#TRUE%$#TRUE
Q9H444%$#Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2)%$#CHMP4B C20orf178 SHAX1%$#TRUE%$#FALSE
Q9NZZ3%$#Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60) (Vps60) (hVps60)%$#CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2%$#FALSE%$#TRUE
Q96FZ7%$#Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20)%$#CHMP6 VPS20%$#TRUE%$#FALSE
Q99653%$#Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22)%$#CHP1 CHP%$#TRUE%$#FALSE
Q6WN34%$#Chordin-like protein 2 (Breast tumor novel factor 1) (BNF-1) (Chordin-related protein 2)%$#CHRDL2 BNF1 CHL2 UNQ765/PRO1557%$#TRUE%$#TRUE
Q9Y3Y2%$#Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG)%$#CHTOP C1orf77 FOP HT031 PP7704%$#FALSE%$#TRUE
Q99828%$#Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)%$#CIB1 CIB KIP PRKDCIP%$#TRUE%$#FALSE
O60543%$#Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A)%$#CIDEA%$#TRUE%$#TRUE
Q07065%$#Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63)%$#CKAP4%$#TRUE%$#FALSE
Q05315%$#Galectin-10 (Gal-10) (Charcot-Leyden crystal protein) (CLC) (Eosinophil lysophospholipase) (Lysolecithin acylhydrolase)%$#CLC LGALS10 LGALS10A%$#TRUE%$#FALSE
Q9Y240%$#C-type lectin domain family 11 member A (C-type lectin superfamily member 3) (Lymphocyte secreted C-type lectin) (Osteolectin) (Stem cell growth factor) (p47)%$#CLEC11A CLECSF3 LSLCL SCGF%$#TRUE%$#FALSE
P05452%$#Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein)%$#CLEC3B TNA%$#TRUE%$#FALSE
O00299%$#Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)%$#CLIC1 G6 NCC27%$#TRUE%$#FALSE
Q9Y696%$#Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1)%$#CLIC4%$#TRUE%$#FALSE
Q96NY7%$#Chloride intracellular channel protein 6 (Parchorin)%$#CLIC6 CLIC1L%$#TRUE%$#FALSE
O94985%$#Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)]%$#CLSTN1 CS1 KIAA0911%$#TRUE%$#TRUE
Q00610%$#Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)%$#CLTC CLH17 CLTCL2 KIAA0034%$#TRUE%$#FALSE
P10909%$#Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2) (SGP-2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]%$#CLU APOJ CLI KUB1 AAG4%$#TRUE%$#TRUE
P30085%$#UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)%$#CMPK1 CMK CMPK UCK UMK UMPK%$#TRUE%$#TRUE
Q96KP4%$#Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Carnosine dipeptidase II) (Epididymis secretory protein Li 13) (Glutamate carboxypeptidase-like protein 1) (Peptidase A)%$#CNDP2 CN2 CPGL HEL-S-13 PEPA%$#TRUE%$#FALSE
Q99439%$#Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin)%$#CNN2%$#TRUE%$#TRUE
P09543%$#2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)%$#CNP%$#TRUE%$#FALSE
Q9Y2B0%$#Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)%$#CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426%$#TRUE%$#FALSE
P26992%$#Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha)%$#CNTFR%$#TRUE%$#FALSE
Q53SF7%$#Cordon-bleu protein-like 1%$#COBLL1 KIAA0977%$#FALSE%$#TRUE
P02462%$#Collagen alpha-1(IV) chain [Cleaved into: Arresten]%$#COL4A1%$#TRUE%$#FALSE
P08572%$#Collagen alpha-2(IV) chain [Cleaved into: Canstatin]%$#COL4A2%$#TRUE%$#TRUE
P21964%$#Catechol O-methyltransferase (EC 2.1.1.6)%$#COMT%$#TRUE%$#FALSE
P53621%$#Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]%$#COPA%$#TRUE%$#FALSE
P53618%$#Coatomer subunit beta (Beta-coat protein) (Beta-COP)%$#COPB1 COPB MSTP026%$#TRUE%$#FALSE
P35606%$#Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)%$#COPB2%$#TRUE%$#FALSE
Q9Y678%$#Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP)%$#COPG1 COPG%$#TRUE%$#FALSE
Q9UBF2%$#Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP)%$#COPG2%$#TRUE%$#FALSE
P61923%$#Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP)%$#COPZ1 COPZ CGI-120 HSPC181%$#TRUE%$#FALSE
P31146%$#Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)%$#CORO1A CORO1%$#TRUE%$#FALSE
Q9BR76%$#Coronin-1B (Coronin-2)%$#CORO1B%$#TRUE%$#FALSE
P13073%$#Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)%$#COX4I1 COX4%$#TRUE%$#FALSE
P00450%$#Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)%$#CP%$#TRUE%$#FALSE
Q96IY4%$#Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)%$#CPB2%$#TRUE%$#TRUE
O75131%$#Copine-3 (Copine III)%$#CPNE3 CPN3 KIAA0636%$#TRUE%$#FALSE
Q9BRF8%$#Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1)%$#CPPED1 CSTP1%$#TRUE%$#FALSE
Q9Y646%$#Carboxypeptidase Q (EC 3.4.17.-) (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase)%$#CPQ LCH1 PGCP%$#TRUE%$#FALSE
Q66K79%$#Carboxypeptidase Z (CPZ) (EC 3.4.17.-)%$#CPZ%$#TRUE%$#FALSE
P29762%$#Cellular retinoic acid-binding protein 1 (Cellular retinoic acid-binding protein I) (CRABP-I)%$#CRABP1 RBP5%$#TRUE%$#FALSE
P29373%$#Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II)%$#CRABP2%$#TRUE%$#FALSE
O75629%$#Protein CREG1 (Cellular repressor of E1A-stimulated genes 1)%$#CREG1 CREG UNQ727/PRO1409%$#TRUE%$#FALSE
P52943%$#Cysteine-rich protein 2 (CRP-2) (Protein ESP1)%$#CRIP2 CRP2%$#TRUE%$#TRUE
Q9H336%$#Cysteine-rich secretory protein LCCL domain-containing 1 (CocoaCrisp) (Cysteine-rich secretory protein 10) (CRISP-10) (LCCL domain-containing cysteine-rich secretory protein 1) (Trypsin inhibitor Hl)%$#CRISPLD1 CRISP10 LCRISP1 UNQ342/PRO541%$#TRUE%$#FALSE
P02741%$#C-reactive protein [Cleaved into: C-reactive protein(1-205)]%$#CRP PTX1%$#TRUE%$#FALSE
Q9Y2S2%$#Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH)%$#CRYL1 CRY%$#TRUE%$#FALSE
Q08257%$#Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)%$#CRYZ%$#TRUE%$#FALSE
P09603%$#Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1]%$#CSF1%$#FALSE%$#TRUE
P15509%$#Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116)%$#CSF2RA CSF2R CSF2RY%$#TRUE%$#FALSE
P47710%$#Alpha-S1-casein [Cleaved into: Casoxin-D]%$#CSN1S1 CASA CSN1%$#TRUE%$#TRUE
P05814%$#Beta-casein%$#CSN2 CASB%$#TRUE%$#TRUE
P07498%$#Kappa-casein%$#CSN3 CASK CSN10 CSNK%$#TRUE%$#TRUE
P48729%$#Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)%$#CSNK1A1%$#TRUE%$#FALSE
P21291%$#Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141)%$#CSRP1 CSRP CYRP%$#TRUE%$#FALSE
P01034%$#Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin)%$#CST3%$#TRUE%$#FALSE
P01040%$#Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed]%$#CSTA STF1 STFA%$#TRUE%$#FALSE
P04080%$#Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B)%$#CSTB CST6 STFB%$#TRUE%$#FALSE
Q01459%$#Di-N-acetylchitobiase (EC 3.2.1.-)%$#CTBS CTB%$#TRUE%$#FALSE
P10619%$#Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain]%$#CTSA PPGB%$#TRUE%$#FALSE
P07858%$#Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]%$#CTSB CPSB%$#TRUE%$#FALSE
P53634%$#Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]%$#CTSC CPPI%$#TRUE%$#FALSE
P07339%$#Cathepsin D (EC 3.4.23.5) [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain]%$#CTSD CPSD%$#TRUE%$#FALSE
P08311%$#Cathepsin G (CG) (EC 3.4.21.20)%$#CTSG%$#TRUE%$#FALSE
P09668%$#Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]%$#CTSH CPSB%$#TRUE%$#FALSE
P25774%$#Cathepsin S (EC 3.4.22.27)%$#CTSS%$#TRUE%$#FALSE
Q9UBR2%$#Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X)%$#CTSZ%$#TRUE%$#FALSE
Q14247%$#Src substrate cortactin (Amplaxin) (Oncogene EMS1)%$#CTTN EMS1%$#TRUE%$#FALSE
O60888%$#Protein CutA (Acetylcholinesterase-associated protein) (Brain acetylcholinesterase putative membrane anchor)%$#CUTA ACHAP C6orf82%$#TRUE%$#FALSE
Q6UXB2%$#C-X-C motif chemokine 17 (6-Cys CXCL17) (Dendritic cell and monocyte chemokine-like protein) (DMC) (VEGF coregulated chemokine 1) [Cleaved into: 4-Cys CXCL17]%$#CXCL17 VCC1 UNQ473/PRO842%$#TRUE%$#FALSE
P19875%$#C-X-C motif chemokine 2 (Growth-regulated protein beta) (Gro-beta) (Macrophage inflammatory protein 2-alpha) (MIP2-alpha) [Cleaved into: GRO-beta(5-73) (GRO-beta-T) (Hematopoietic synergistic factor) (HSF) (SB-251353)]%$#CXCL2 GRO2 GROB MIP2A SCYB2%$#TRUE%$#FALSE
P25025%$#C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182)%$#CXCR2 IL8RB%$#TRUE%$#FALSE
O14569%$#Cytochrome b561 domain-containing protein 2 (EC 7.2.1.3) (Putative tumor suppressor protein 101F6) (Transmembrane ascorbate ferrireductase)%$#CYB561D2 101F6 LUCA12.2%$#TRUE%$#FALSE
P00167%$#Cytochrome b5 (Microsomal cytochrome b5 type A) (MCB5)%$#CYB5A CYB5%$#TRUE%$#FALSE
O43169%$#Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform)%$#CYB5B CYB5M OMB5%$#TRUE%$#FALSE
P04839%$#Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)%$#CYBB NOX2%$#TRUE%$#FALSE
Q53TN4%$#Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3)%$#CYBRD1 DCYTB FRRS3%$#TRUE%$#TRUE
P98082%$#Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2)%$#DAB2 DOC2%$#TRUE%$#FALSE
Q14118%$#Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]%$#DAG1%$#TRUE%$#FALSE
P14868%$#Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)%$#DARS PIG40%$#TRUE%$#FALSE
P07108%$#Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP)%$#DBI%$#TRUE%$#FALSE
Q9UJU6%$#Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7)%$#DBNL CMAP SH3P7 PP5423%$#TRUE%$#FALSE
P81605%$#Dermcidin (EC 3.4.-.-) (Preproteolysin) [Cleaved into: Survival-promoting peptide; DCD-1]%$#DCD AIDD DSEP%$#TRUE%$#FALSE
Q14203%$#Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued)%$#DCTN1%$#TRUE%$#FALSE
Q7Z4W1%$#L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)%$#DCXR SDR20C1%$#TRUE%$#FALSE
O94760%$#N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)%$#DDAH1 DDAH%$#TRUE%$#FALSE
P39656%$#Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit)%$#DDOST KIAA0115 OST48 OK/SW-cl.45%$#TRUE%$#FALSE
Q08345%$#Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)%$#DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE%$#TRUE%$#FALSE
P30046%$#D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II)%$#DDT%$#TRUE%$#FALSE
Q92499%$#ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB)%$#DDX1%$#TRUE%$#FALSE
Q96FC9%$#ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (CHL1-related protein 1) (hCHLR1) (DEAD/H-box protein 11) (Keratinocyte growth factor-regulated gene 2 protein) (KRG-2)%$#DDX11 CHL1 CHLR1 KRG2%$#FALSE%$#TRUE
Q92841%$#Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)%$#DDX17%$#TRUE%$#FALSE
Q13838%$#Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)%$#DDX39B BAT1 UAP56%$#TRUE%$#FALSE
O00571%$#ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)%$#DDX3X DBX DDX3%$#TRUE%$#TRUE
P59666%$#Neutrophil defensin 3 (Defensin, alpha 3) (HNP-3) (HP-3) (HP3) [Cleaved into: HP 3-56; Neutrophil defensin 2 (HNP-2) (HP-2) (HP2)]%$#DEFA3 DEF3%$#TRUE%$#FALSE
P60022%$#Beta-defensin 1 (BD-1) (hBD-1) (Defensin, beta 1)%$#DEFB1 BD1 HBD1%$#TRUE%$#FALSE
O43583%$#Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3)%$#DENR DRP1 H14%$#TRUE%$#FALSE
Q96LJ7%$#Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 19C member 1)%$#DHRS1 SDR19C1%$#TRUE%$#FALSE
O75911%$#Short-chain dehydrogenase/reductase 3 (EC 1.1.1.300) (DD83.1) (Retinal short-chain dehydrogenase/reductase 1) (retSDR1) (Retinol dehydrogenase 17) (Short chain dehydrogenase/reductase family 16C member 1)%$#DHRS3 RDH17 SDR16C1 UNQ2424/PRO4983%$#TRUE%$#FALSE
Q9Y394%$#Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)%$#DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448%$#TRUE%$#FALSE
P09622%$#Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)%$#DLD GCSL LAD PHE3%$#TRUE%$#FALSE
Q9UBS4%$#DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4)%$#DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080%$#TRUE%$#FALSE
Q13217%$#DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)%$#DNAJC3 P58IPK PRKRI%$#TRUE%$#FALSE
Q9H3Z4%$#DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein) (CSP)%$#DNAJC5 CLN4%$#TRUE%$#TRUE
P50570%$#Dynamin-2 (EC 3.6.5.5)%$#DNM2 DYN2%$#TRUE%$#FALSE
O43598%$#2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL)%$#DNPH1 C6orf108 RCL%$#TRUE%$#FALSE
Q9P2X0%$#Dolichol-phosphate mannosyltransferase subunit 3 (Dolichol-phosphate mannose synthase subunit 3) (DPM synthase subunit 3) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 3) (Mannose-P-dolichol synthase subunit 3) (MPD synthase subunit 3) (Prostin-1)%$#DPM3%$#TRUE%$#FALSE
Q9NY33%$#Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) (Enkephalinase B)%$#DPP3%$#TRUE%$#FALSE
Q9UHL4%$#Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)%$#DPP7 DPP2 QPP%$#TRUE%$#FALSE
Q16555%$#Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2)%$#DPYSL2 CRMP2 ULIP2%$#TRUE%$#FALSE
Q14195%$#Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1)%$#DPYSL3 CRMP4 DRP3 ULIP ULIP1%$#TRUE%$#FALSE
Q02487%$#Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III)%$#DSC2 CDHF2 DSC3%$#TRUE%$#FALSE
Q14126%$#Desmoglein-2 (Cadherin family member 5) (HDGC)%$#DSG2 CDHF5%$#FALSE%$#TRUE
P60981%$#Destrin (Actin-depolymerizing factor) (ADF)%$#DSTN ACTDP DSN%$#TRUE%$#FALSE
Q14204%$#Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)%$#DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325%$#TRUE%$#FALSE
Q13409%$#Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)%$#DYNC1I2 DNCI2 DNCIC2%$#TRUE%$#FALSE
P63167%$#Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (DLC8) (Dynein light chain LC8-type 1) (Protein inhibitor of neuronal nitric oxide synthase) (PIN)%$#DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1%$#TRUE%$#FALSE
Q15125%$#3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)%$#EBP%$#TRUE%$#FALSE
P68104%$#Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)%$#EEF1A1 EEF1A EF1A LENG7%$#TRUE%$#TRUE
P24534%$#Elongation factor 1-beta (EF-1-beta)%$#EEF1B2 EEF1B EF1B%$#TRUE%$#FALSE
P29692%$#Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4)%$#EEF1D EF1D%$#TRUE%$#TRUE
P26641%$#Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)%$#EEF1G EF1G PRO1608%$#TRUE%$#FALSE
P13639%$#Elongation factor 2 (EF-2)%$#EEF2 EF2%$#TRUE%$#FALSE
Q12805%$#EGF-containing fibulin-like extracellular matrix protein 1 (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3)%$#EFEMP1 FBLN3 FBNL%$#TRUE%$#FALSE
Q9BUP0%$#EF-hand domain-containing protein D1 (EF-hand domain-containing protein 1) (Swiprosin-2)%$#EFHD1 SWS2 PP3051%$#TRUE%$#FALSE
Q96C19%$#EF-hand domain-containing protein D2 (Swiprosin-1)%$#EFHD2 SWS1%$#TRUE%$#TRUE
P20827%$#Ephrin-A1 (EPH-related receptor tyrosine kinase ligand 1) (LERK-1) (Immediate early response protein B61) (Tumor necrosis factor alpha-induced protein 4) (TNF alpha-induced protein 4) [Cleaved into: Ephrin-A1, secreted form]%$#EFNA1 EPLG1 LERK1 TNFAIP4%$#TRUE%$#FALSE
P01133%$#Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)]%$#EGF%$#TRUE%$#FALSE
Q9H4M9%$#EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin)%$#EHD1 PAST PAST1 CDABP0131%$#TRUE%$#FALSE
Q9H223%$#EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4)%$#EHD4 HCA10 HCA11 PAST4 FKSG7%$#TRUE%$#FALSE
P41567%$#Eukaryotic translation initiation factor 1 (eIF1) (A121) (Protein translation factor SUI1 homolog) (Sui1iso1)%$#EIF1 SUI1%$#FALSE%$#TRUE
O14602%$#Eukaryotic translation initiation factor 1A, Y-chromosomal (eIF-1A Y isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C)%$#EIF1AY%$#FALSE%$#TRUE
O60739%$#Eukaryotic translation initiation factor 1b (eIF1b) (Protein translation factor SUI1 homolog GC20)%$#EIF1B%$#TRUE%$#FALSE
P05198%$#Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)%$#EIF2S1 EIF2A%$#TRUE%$#FALSE
P20042%$#Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)%$#EIF2S2 EIF2B%$#TRUE%$#TRUE
P41091%$#Eukaryotic translation initiation factor 2 subunit 3 (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF-2-gamma X) (eIF-2gX)%$#EIF2S3 EIF2G%$#TRUE%$#FALSE
Q14152%$#Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185)%$#EIF3A EIF3S10 KIAA0139%$#TRUE%$#FALSE
P55884%$#Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)%$#EIF3B EIF3S9%$#TRUE%$#FALSE
Q99613%$#Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)%$#EIF3C EIF3S8%$#TRUE%$#FALSE
O15371%$#Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)%$#EIF3D EIF3S7%$#TRUE%$#FALSE
P60228%$#Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)%$#EIF3E EIF3S6 INT6%$#TRUE%$#FALSE
O00303%$#Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)%$#EIF3F EIF3S5%$#TRUE%$#FALSE
O75821%$#Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)%$#EIF3G EIF3S4%$#TRUE%$#FALSE
O15372%$#Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)%$#EIF3H EIF3S3%$#TRUE%$#FALSE
Q13347%$#Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1) (TRIP-1) (eIF-3-beta) (eIF3 p36)%$#EIF3I EIF3S2 TRIP1%$#TRUE%$#FALSE
O75822%$#Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35)%$#EIF3J EIF3S1 PRO0391%$#TRUE%$#TRUE
Q9Y262%$#Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein)%$#EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005%$#TRUE%$#FALSE
P60842%$#Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)%$#EIF4A1 DDX2A EIF4A%$#TRUE%$#FALSE
Q14240%$#Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)%$#EIF4A2 DDX2B EIF4F%$#TRUE%$#FALSE
Q04637%$#Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220)%$#EIF4G1 EIF4F EIF4G EIF4GI%$#TRUE%$#FALSE
Q15056%$#Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein)%$#EIF4H KIAA0038 WBSCR1 WSCR1%$#TRUE%$#FALSE
P63241%$#Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D)%$#EIF5A%$#TRUE%$#FALSE
P08246%$#Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)%$#ELANE ELA2%$#TRUE%$#FALSE
Q8IZ81%$#ELMO domain-containing protein 2%$#ELMOD2%$#TRUE%$#FALSE
Q9BW60%$#Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1)%$#ELOVL1 SSC1 CGI-88%$#FALSE%$#TRUE
O95834%$#Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2)%$#EML2 EMAP2 EMAPL2%$#TRUE%$#FALSE
P17813%$#Endoglin (CD antigen CD105)%$#ENG END%$#TRUE%$#FALSE
P06733%$#Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)%$#ENO1 ENO1L1 MBPB1 MPB1%$#TRUE%$#FALSE
Q9UHY7%$#Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)%$#ENOPH1 MASA MSTP145%$#TRUE%$#FALSE
O43768%$#Alpha-endosulfine (ARPP-19e)%$#ENSA%$#FALSE%$#TRUE
O75355%$#Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6)%$#ENTPD3 CD39L3%$#TRUE%$#FALSE
P16422%$#Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326)%$#EPCAM GA733-2 M1S2 M4S1 MIC18 TACSTD1 TROP1%$#TRUE%$#FALSE
Q15375%$#Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11)%$#EPHA7 EHK3 HEK11%$#TRUE%$#FALSE
P58107%$#Epiplakin (450 kDa epidermal antigen)%$#EPPK1 EPIPL%$#TRUE%$#FALSE
P07814%$#Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)]%$#EPRS GLNS PARS QARS QPRS PIG32%$#TRUE%$#FALSE
Q9H6S3%$#Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2)%$#EPS8L2 EPS8R2 PP13181%$#TRUE%$#FALSE
P11678%$#Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain]%$#EPX EPER EPO EPP%$#TRUE%$#FALSE
Q9NZ08%$#Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)%$#ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154%$#TRUE%$#FALSE
Q969X5%$#Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32)%$#ERGIC1 ERGIC32 KIAA1181 HT034%$#TRUE%$#FALSE
O94905%$#Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2)%$#ERLIN2 C8orf2 SPFH2 UNQ2441/PRO5003/PRO9924%$#TRUE%$#FALSE
Q96HE7%$#ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)%$#ERO1A ERO1L UNQ434/PRO865%$#TRUE%$#FALSE
P30040%$#Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)%$#ERP29 C12orf8 ERP28%$#TRUE%$#FALSE
Q9BS26%$#Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)%$#ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075%$#TRUE%$#FALSE
P10768%$#S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56)%$#ESD%$#TRUE%$#FALSE
P34910%$#Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361)%$#EVI2B EVDB%$#FALSE%$#TRUE
P15311%$#Ezrin (Cytovillin) (Villin-2) (p81)%$#EZR VIL2%$#TRUE%$#FALSE
P00488%$#Coagulation factor XIII A chain (Coagulation factor XIIIa) (EC 2.3.2.13) (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)%$#F13A1 F13A%$#FALSE%$#TRUE
P00734%$#Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]%$#F2%$#TRUE%$#TRUE
P05413%$#Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP) (Mammary-derived growth inhibitor) (MDGI) (Muscle fatty acid-binding protein) (M-FABP)%$#FABP3 FABP11 MDGI%$#TRUE%$#FALSE
Q01469%$#Fatty acid-binding protein 5 (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein, epidermal) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP)%$#FABP5%$#TRUE%$#FALSE
O15540%$#Fatty acid-binding protein, brain (Brain lipid-binding protein) (BLBP) (Brain-type fatty acid-binding protein) (B-FABP) (Fatty acid-binding protein 7) (Mammary-derived growth inhibitor related)%$#FABP7 BLBP FABPB MRG%$#TRUE%$#FALSE
P16930%$#Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)%$#FAH%$#TRUE%$#FALSE
Q9H098%$#Protein FAM107B%$#FAM107B C10orf45%$#TRUE%$#TRUE
Q96MK3%$#Pseudokinase FAM20A%$#FAM20A UNQ9388/PRO34279%$#TRUE%$#FALSE
P58499%$#Protein FAM3B (Cytokine-like protein 2-21) (Pancreatic-derived factor) (PANDER)%$#FAM3B C21orf11 C21orf76 PRED44 UNQ320/PRO365%$#TRUE%$#TRUE
Q92520%$#Protein FAM3C (Interleukin-like EMT inducer)%$#FAM3C ILEI GS3786%$#TRUE%$#FALSE
Q9NUQ9%$#Protein FAM49B (L1)%$#FAM49B BM-009%$#TRUE%$#FALSE
Q9Y285%$#Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)%$#FARSA FARS FARSL FARSLA%$#TRUE%$#FALSE
Q9NSD9%$#Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)%$#FARSB FARSLB FRSB HSPC173%$#TRUE%$#FALSE
P49327%$#Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]%$#FASN FAS%$#TRUE%$#TRUE
Q9NYQ8%$#Protocadherin Fat 2 (hFat2) (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1)%$#FAT2 CDHF8 KIAA0811 MEGF1%$#TRUE%$#FALSE
P62861%$#40S ribosomal protein S30 (Small ribosomal subunit protein eS30)%$#FAU%$#FALSE%$#TRUE
P23142%$#Fibulin-1 (FIBL-1)%$#FBLN1 PP213%$#TRUE%$#FALSE
Q9UBX5%$#Fibulin-5 (FIBL-5) (Developmental arteries and neural crest EGF-like protein) (Dance) (Urine p50 protein) (UP50)%$#FBLN5 DANCE UNQ184/PRO210%$#TRUE%$#FALSE
P09467%$#Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)%$#FBP1 FBP%$#TRUE%$#FALSE
O00757%$#Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)%$#FBP2%$#TRUE%$#FALSE
Q9Y6R7%$#IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP)%$#FCGBP%$#TRUE%$#FALSE
O00602%$#Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)%$#FCN1 FCNM%$#TRUE%$#FALSE
Q15485%$#Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)%$#FCN2 FCNL%$#TRUE%$#FALSE
Q8NFU4%$#Follicular dendritic cell secreted peptide (FDC secreted protein) (FDC-SP)%$#FDCSP C4orf7 UNQ733/PRO1419%$#FALSE%$#TRUE
P14324%$#Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)%$#FDPS FPS KIAA1293%$#TRUE%$#FALSE
Q86UX7%$#Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2)%$#FERMT3 KIND3 MIG2B URP2%$#TRUE%$#FALSE
P02671%$#Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]%$#FGA%$#TRUE%$#TRUE
P02675%$#Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]%$#FGB%$#TRUE%$#TRUE
Q14512%$#Fibroblast growth factor-binding protein 1 (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17)%$#FGFBP1 FGFBP HBP17%$#TRUE%$#FALSE
P02679%$#Fibrinogen gamma chain%$#FGG PRO2061%$#TRUE%$#TRUE
Q9Y3D6%$#Mitochondrial fission 1 protein (FIS1 homolog) (hFis1) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11)%$#FIS1 TTC11 CGI-135%$#TRUE%$#FALSE
P62942%$#Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase)%$#FKBP1A FKBP1 FKBP12%$#TRUE%$#FALSE
P26885%$#Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)%$#FKBP2 FKBP13%$#TRUE%$#FALSE
Q00688%$#Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase)%$#FKBP3 FKBP25%$#TRUE%$#FALSE
Q02790%$#Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]%$#FKBP4 FKBP52%$#TRUE%$#FALSE
P21333%$#Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)%$#FLNA FLN FLN1%$#TRUE%$#FALSE
O75369%$#Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP)%$#FLNB FLN1L FLN3 TABP TAP%$#TRUE%$#FALSE
O75955%$#Flotillin-1%$#FLOT1%$#TRUE%$#FALSE
Q14254%$#Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1)%$#FLOT2 ESA1 M17S1%$#TRUE%$#FALSE
P02751%$#Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]%$#FN1 FN%$#TRUE%$#FALSE
Q04609%$#Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)%$#FOLH1 FOLH NAALAD1 PSM PSMA GIG27%$#TRUE%$#FALSE
P15328%$#Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18)%$#FOLR1 FOLR%$#TRUE%$#FALSE
Q16658%$#Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55)%$#FSCN1 FAN1 HSN SNL%$#TRUE%$#FALSE
Q12841%$#Follistatin-related protein 1 (Follistatin-like protein 1)%$#FSTL1 FRP%$#TRUE%$#FALSE
P02794%$#Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]%$#FTH1 FTH FTHL6 OK/SW-cl.84 PIG15%$#TRUE%$#FALSE
P04066%$#Tissue alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1) (Alpha-L-fucosidase 1)%$#FUCA1 Nbla10230%$#TRUE%$#FALSE
P21217%$#Galactoside 3(4)-L-fucosyltransferase (EC 2.4.1.65) (Blood group Lewis alpha-4-fucosyltransferase) (Lewis FT) (Fucosyltransferase 3) (Fucosyltransferase III) (FucT-III)%$#FUT3 FT3B LE%$#TRUE%$#FALSE
P51993%$#Alpha-(1,3)-fucosyltransferase 6 (EC 2.4.1.65) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase)%$#FUT6 FCT3A%$#TRUE%$#FALSE
P11413%$#Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)%$#G6PD%$#TRUE%$#TRUE
Q14376%$#UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)%$#GALE%$#TRUE%$#FALSE
P51570%$#Galactokinase (EC 2.7.1.6) (Galactose kinase)%$#GALK1 GALK%$#TRUE%$#FALSE
Q10472%$#Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]%$#GALNT1%$#TRUE%$#FALSE
Q10471%$#Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]%$#GALNT2%$#TRUE%$#TRUE
Q14697%$#Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha)%$#GANAB G2AN KIAA0088%$#TRUE%$#FALSE
P04406%$#Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)%$#GAPDH GAPD CDABP0047 OK/SW-cl.12%$#TRUE%$#FALSE
P04062%$#Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.104) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase)%$#GBA GC GLUC%$#TRUE%$#FALSE
P32455%$#Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (HuGBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1)%$#GBP1%$#TRUE%$#FALSE
P02774%$#Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)%$#GC%$#TRUE%$#FALSE
P28676%$#Grancalcin%$#GCA GCL%$#TRUE%$#TRUE
P48506%$#Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)%$#GCLC GLCL GLCLC%$#TRUE%$#FALSE
P31150%$#Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4)%$#GDI1 GDIL OPHN2 RABGDIA XAP4%$#TRUE%$#FALSE
P50395%$#Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)%$#GDI2 RABGDIB%$#TRUE%$#FALSE
Q06210%$#Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)%$#GFPT1 GFAT GFPT%$#TRUE%$#FALSE
O75223%$#Gamma-glutamylcyclotransferase (EC 4.3.2.9) (Cytochrome c-releasing factor 21)%$#GGCT C7orf24 CRF21%$#TRUE%$#FALSE
Q92820%$#Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)%$#GGH%$#TRUE%$#FALSE
P19440%$#Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]%$#GGT1 GGT%$#TRUE%$#FALSE
P36269%$#Glutathione hydrolase 5 proenzyme (EC 3.4.19.13) (Gamma-glutamyl transpeptidase-related enzyme) (GGT-rel) (Gamma-glutamyltransferase 5) (GGT 5) (EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain]%$#GGT5 GGTLA1%$#TRUE%$#FALSE
O14908%$#PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2)%$#GIPC1 C19orf3 GIPC RGS19IP1%$#TRUE%$#FALSE
P16278%$#Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)%$#GLB1 ELNR1%$#TRUE%$#FALSE
Q92896%$#Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160)%$#GLG1 CFR1 ESL1 MG160%$#TRUE%$#TRUE
Q9H4G4%$#Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)%$#GLIPR2 C9orf19 GAPR1%$#TRUE%$#FALSE
Q9HC38%$#Glyoxalase domain-containing protein 4%$#GLOD4 C17orf25 CGI-150 My027%$#TRUE%$#FALSE
P35754%$#Glutaredoxin-1 (Thioltransferase-1) (TTase-1)%$#GLRX GRX%$#TRUE%$#FALSE
O76003%$#Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2)%$#GLRX3 PICOT TXNL2 HUSSY-22%$#TRUE%$#FALSE
P00367%$#Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)%$#GLUD1 GLUD%$#TRUE%$#FALSE
P15104%$#Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)%$#GLUL GLNS%$#TRUE%$#FALSE
P17900%$#Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short]%$#GM2A%$#TRUE%$#FALSE
O60547%$#GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)%$#GMDS%$#TRUE%$#FALSE
O60234%$#Glia maturation factor gamma (GMF-gamma)%$#GMFG%$#TRUE%$#FALSE
Q96IJ6%$#Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)%$#GMPPA%$#TRUE%$#FALSE
Q9Y5P6%$#Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)%$#GMPPB%$#TRUE%$#FALSE
P29992%$#Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha)%$#GNA11 GA11%$#TRUE%$#FALSE
Q14344%$#Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)%$#GNA13%$#TRUE%$#FALSE
P63096%$#Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein)%$#GNAI1%$#TRUE%$#FALSE
P04899%$#Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein)%$#GNAI2 GNAI2B%$#TRUE%$#FALSE
P08754%$#Guanine nucleotide-binding protein G(i) subunit alpha (G(i) alpha-3)%$#GNAI3%$#TRUE%$#FALSE
P50148%$#Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)%$#GNAQ GAQ%$#TRUE%$#FALSE
Q5JWF2%$#Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)%$#GNAS GNAS1%$#TRUE%$#FALSE
P62873%$#Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)%$#GNB1%$#TRUE%$#FALSE
P62879%$#Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2)%$#GNB2%$#TRUE%$#TRUE
Q9HAV0%$#Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4)%$#GNB4%$#TRUE%$#FALSE
Q9UBI6%$#Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12%$#GNG12%$#TRUE%$#FALSE
P63218%$#Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5%$#GNG5 GNGT5%$#TRUE%$#FALSE
Q96EK6%$#Glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase)%$#GNPNAT1 GNA1%$#TRUE%$#FALSE
Q9UJJ9%$#N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma)%$#GNPTG C16orf27 GNPTAG CAB56184 LP2537%$#TRUE%$#FALSE
P15586%$#N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)%$#GNS%$#TRUE%$#FALSE
Q7Z5G4%$#Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa)%$#GOLGA7 GCP16 HDCKB03P HSPC041%$#TRUE%$#FALSE
P17174%$#Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)%$#GOT1%$#TRUE%$#FALSE
Q86UL3%$#Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7)%$#GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108%$#TRUE%$#FALSE
Q8N335%$#Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1-L) (EC 1.1.1.8)%$#GPD1L KIAA0089%$#TRUE%$#FALSE
P06744%$#Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)%$#GPI%$#TRUE%$#FALSE
Q9NZH0%$#G-protein coupled receptor family C group 5 member B (A-69G12.1) (Retinoic acid-induced gene 2 protein) (RAIG-2)%$#GPRC5B RAIG2%$#TRUE%$#TRUE
Q9NQ84%$#G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3)%$#GPRC5C RAIG3 PSEC0087%$#TRUE%$#TRUE
P24298%$#Alanine aminotransferase 1 (ALT1) (EC 2.6.1.2) (Glutamate pyruvate transaminase 1) (GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1)%$#GPT AAT1 GPT1%$#TRUE%$#FALSE
P22352%$#Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P)%$#GPX3 GPXP%$#TRUE%$#TRUE
P36969%$#Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)%$#GPX4%$#TRUE%$#FALSE
P62993%$#Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2)%$#GRB2 ASH%$#TRUE%$#FALSE
Q9H772%$#Gremlin-2 (Cysteine knot superfamily 1, BMP antagonist 2) (DAN domain family member 3) (Protein related to DAN and cerberus)%$#GREM2 CKTSF1B2 DAND3 PRDC%$#TRUE%$#TRUE
P06396%$#Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin)%$#GSN%$#TRUE%$#FALSE
P48637%$#Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)%$#GSS%$#TRUE%$#FALSE
P08263%$#Glutathione S-transferase A1 (EC 2.5.1.18) (13-hydroperoxyoctadecadienoate peroxidase) (EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase) (EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed]%$#GSTA1%$#TRUE%$#FALSE
Q9Y2Q3%$#Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13)%$#GSTK1 HDCMD47P%$#TRUE%$#FALSE
P09488%$#Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4)%$#GSTM1 GST1%$#TRUE%$#FALSE
P21266%$#Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3)%$#GSTM3 GST5%$#TRUE%$#FALSE
P78417%$#Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)%$#GSTO1 GSTTLP28%$#TRUE%$#FALSE
P09211%$#Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1)%$#GSTP1 FAEES3 GST3%$#TRUE%$#FALSE
P46976%$#Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)%$#GYG1 GYG%$#TRUE%$#FALSE
P07305%$#Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed]%$#H1F0 H1FV%$#TRUE%$#FALSE
Q92522%$#Histone H1x%$#H1FX%$#FALSE%$#TRUE
O75367%$#Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205)%$#H2AFY MACROH2A1%$#TRUE%$#FALSE
P0C0S5%$#Histone H2A.Z (H2A/z)%$#H2AFZ H2AZ%$#TRUE%$#FALSE
P40939%$#Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]%$#HADHA HADH%$#TRUE%$#FALSE
Q96S86%$#Hyaluronan and proteoglycan link protein 3%$#HAPLN3 EXLD1 UNQ238/PRO271%$#TRUE%$#TRUE
P69905%$#Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain)%$#HBA1; HBA2%$#TRUE%$#FALSE
P68871%$#Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]%$#HBB%$#TRUE%$#FALSE
P14317%$#Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75)%$#HCLS1 HS1%$#FALSE%$#TRUE
Q00341%$#Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)%$#HDLBP HBP VGL%$#TRUE%$#FALSE
Q9NRV9%$#Heme-binding protein 1 (p22HBP)%$#HEBP1 HBP%$#TRUE%$#FALSE
Q9Y5Z4%$#Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)%$#HEBP2 C6orf34 SOUL%$#TRUE%$#FALSE
P06865%$#Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)%$#HEXA%$#TRUE%$#FALSE
P07686%$#Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]%$#HEXB HCC7%$#TRUE%$#FALSE
Q6NVY1%$#3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)%$#HIBCH%$#TRUE%$#FALSE
P49773%$#Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)%$#HINT1 HINT PKCI1 PRKCNH1%$#TRUE%$#FALSE
Q9NQE9%$#Histidine triad nucleotide-binding protein 3 (HINT-3) (EC 3.-.-.-)%$#HINT3%$#TRUE%$#FALSE
P16401%$#Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3)%$#HIST1H1B H1F5%$#TRUE%$#TRUE
P16403%$#Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1)%$#HIST1H1C H1F2%$#TRUE%$#TRUE
P16402%$#Histone H1.3 (Histone H1c) (Histone H1s-2)%$#HIST1H1D H1F3%$#FALSE%$#TRUE
P10412%$#Histone H1.4 (Histone H1b) (Histone H1s-4)%$#HIST1H1E H1F4%$#FALSE%$#TRUE
P04908%$#Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)%$#HIST1H2AB H2AFM; HIST1H2AE H2AFA%$#TRUE%$#FALSE
P06899%$#Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)%$#HIST1H2BJ H2BFR%$#TRUE%$#FALSE
O60814%$#Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)%$#HIST1H2BK H2BFT HIRIP1%$#TRUE%$#TRUE
Q99879%$#Histone H2B type 1-M (Histone H2B.e) (H2B/e)%$#HIST1H2BM H2BFE%$#FALSE%$#TRUE
P23527%$#Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)%$#HIST1H2BO H2BFH H2BFN%$#FALSE%$#TRUE
P62805%$#Histone H4%$#HIST1H4A H4/A H4FA; HIST1H4B H4/I H4FI; HIST1H4C H4/G H4FG; HIST1H4D H4/B H4FB; HIST1H4E H4/J H4FJ; HIST1H4F H4/C H4FC; HIST1H4H H4/H H4FH; HIST1H4I H4/M H4FM; HIST1H4J H4/E H4FE; HIST1H4K H4/D H4FD; HIST1H4L H4/K H4FK; HIST2H4A H4/N H4F2 H4FN HIST2H4; HIST2H4B H4/O H4FO; HIST4H4%$#TRUE%$#FALSE
P52790%$#Hexokinase-3 (EC 2.7.1.1) (Hexokinase type III) (HK III) (Hexokinase-C)%$#HK3%$#TRUE%$#TRUE
P16188%$#HLA class I histocompatibility antigen, A-30 alpha chain (MHC class I antigen A*30)%$#HLA-A HLAA%$#TRUE%$#TRUE
P16190%$#HLA class I histocompatibility antigen, A-33 alpha chain (Aw-19) (Aw-33) (MHC class I antigen A*33)%$#HLA-A HLAA%$#TRUE%$#FALSE
P04439%$#HLA class I histocompatibility antigen, A-3 alpha chain (Human leukocyte antigen A*03) (HLA-A*03)%$#HLA-A HLAA%$#TRUE%$#FALSE
P16189%$#HLA class I histocompatibility antigen, A-31 alpha chain (MHC class I antigen A*31)%$#HLA-A HLAA%$#FALSE%$#TRUE
Q29718%$#HLA class I histocompatibility antigen, B-82 alpha chain (MHC class I antigen B*82)%$#HLA-B HLAB%$#TRUE%$#FALSE
P30491%$#HLA class I histocompatibility antigen, B-53 alpha chain (Bw-53) (MHC class I antigen B*53)%$#HLA-B HLAB%$#TRUE%$#FALSE
P30483%$#HLA class I histocompatibility antigen, B-45 alpha chain (Bw-45) (MHC class I antigen B*45)%$#HLA-B HLAB%$#TRUE%$#FALSE
P10321%$#HLA class I histocompatibility antigen, Cw-7 alpha chain (MHC class I antigen Cw*7)%$#HLA-C HLAC%$#FALSE%$#TRUE
P01903%$#HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)%$#HLA-DRA HLA-DRA1%$#TRUE%$#FALSE
P20039%$#HLA class II histocompatibility antigen, DRB1-11 beta chain (DR-5) (DR5) (DRw11) (MHC class II antigen DRB1*11)%$#HLA-DRB1%$#TRUE%$#FALSE
P04229%$#HLA class II histocompatibility antigen, DRB1-1 beta chain (MHC class II antigen DRB1*1) (DR-1) (DR1)%$#HLA-DRB1%$#TRUE%$#FALSE
P01911%$#HLA class II histocompatibility antigen, DRB1-15 beta chain (DW2.2/DR2.2) (MHC class II antigen DRB1*15)%$#HLA-DRB1 HLA-DRB2%$#TRUE%$#FALSE
Q30154%$#HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)%$#HLA-DRB5%$#TRUE%$#FALSE
Q8TCT9%$#Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase)%$#HM13 H13 IMP1 PSL3 SPP MSTP086%$#TRUE%$#FALSE
P09429%$#High mobility group protein B1 (High mobility group protein 1) (HMG-1)%$#HMGB1 HMG1%$#TRUE%$#TRUE
P26583%$#High mobility group protein B2 (High mobility group protein 2) (HMG-2)%$#HMGB2 HMG2%$#TRUE%$#TRUE
P05204%$#Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2)%$#HMGN2 HMG17%$#FALSE%$#TRUE
P09651%$#Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]%$#HNRNPA1 HNRPA1%$#TRUE%$#FALSE
P22626%$#Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)%$#HNRNPA2B1 HNRPA2B1%$#TRUE%$#FALSE
P51991%$#Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3)%$#HNRNPA3 HNRPA3%$#TRUE%$#FALSE
P07910%$#Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2)%$#HNRNPC HNRPC%$#TRUE%$#FALSE
Q14103%$#Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1)%$#HNRNPD AUF1 HNRPD%$#TRUE%$#FALSE
P52597%$#Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]%$#HNRNPF HNRPF%$#TRUE%$#FALSE
P61978%$#Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP)%$#HNRNPK HNRPK%$#TRUE%$#FALSE
P14866%$#Heterogeneous nuclear ribonucleoprotein L (hnRNP L)%$#HNRNPL HNRPL P/OKcl.14%$#TRUE%$#FALSE
P52272%$#Heterogeneous nuclear ribonucleoprotein M (hnRNP M)%$#HNRNPM HNRPM NAGR1%$#TRUE%$#TRUE
Q00839%$#Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A) (SAF-A) (p120) (pp120)%$#HNRNPU C1orf199 HNRPU SAFA U21.1%$#TRUE%$#FALSE
P00738%$#Haptoglobin (Zonulin) [Cleaved into: Haptoglobin alpha chain; Haptoglobin beta chain]%$#HP%$#TRUE%$#FALSE
Q5SSJ5%$#Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74)%$#HP1BP3%$#FALSE%$#TRUE
P00492%$#Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)%$#HPRT1 HPRT%$#TRUE%$#FALSE
P02790%$#Hemopexin (Beta-1B-glycoprotein)%$#HPX%$#TRUE%$#FALSE
P04196%$#Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)%$#HRG%$#TRUE%$#FALSE
Q86YZ3%$#Hornerin%$#HRNR S100A18%$#TRUE%$#FALSE
Q53GQ0%$#Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 1)%$#HSD17B12 SDR12C1%$#TRUE%$#FALSE
P51659%$#Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]%$#HSD17B4 EDH17B4 SDR8C1%$#TRUE%$#FALSE
P56937%$#3-keto-steroid reductase (EC 1.1.1.270) (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 37C member 1)%$#HSD17B7 SDR37C1 UNQ2563/PRO6243%$#TRUE%$#FALSE
P07900%$#Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)%$#HSP90AA1 HSP90A HSPC1 HSPCA%$#TRUE%$#FALSE
P08238%$#Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)%$#HSP90AB1 HSP90B HSPC2 HSPCB%$#TRUE%$#FALSE
P14625%$#Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog)%$#HSP90B1 GRP94 TRA1%$#TRUE%$#FALSE
P48723%$#Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein)%$#HSPA13 STCH%$#TRUE%$#FALSE
P0DMV8%$#Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1)%$#HSPA1A HSP72 HSPA1 HSX70%$#TRUE%$#TRUE
P34932%$#Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2)%$#HSPA4 APG2%$#TRUE%$#FALSE
P11021%$#Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)%$#HSPA5 GRP78%$#TRUE%$#FALSE
P11142%$#Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)%$#HSPA8 HSC70 HSP73 HSPA10%$#TRUE%$#FALSE
P38646%$#Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (MOT) (Peptide-binding protein 74) (PBP74)%$#HSPA9 GRP75 HSPA9B mt-HSP70%$#TRUE%$#FALSE
P04792%$#Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)%$#HSPB1 HSP27 HSP28%$#TRUE%$#TRUE
P10809%$#60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)%$#HSPD1 HSP60%$#TRUE%$#FALSE
P61604%$#10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10) (Early-pregnancy factor) (EPF)%$#HSPE1%$#TRUE%$#FALSE
Q9BUP3%$#Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)%$#HTATIP2 CC3 TIP30%$#TRUE%$#FALSE
Q9Y4L1%$#Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)%$#HYOU1 GRP170 ORP150%$#TRUE%$#FALSE
P05362%$#Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54)%$#ICAM1%$#TRUE%$#FALSE
O75874%$#Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)%$#IDH1 PICD%$#TRUE%$#FALSE
P48735%$#Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)%$#IDH2%$#TRUE%$#FALSE
Q01628%$#Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U)%$#IFITM3%$#TRUE%$#FALSE
P11717%$#Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222)%$#IGF2R MPRI%$#TRUE%$#FALSE
P18065%$#Insulin-like growth factor-binding protein 2 (IBP-2) (IGF-binding protein 2) (IGFBP-2)%$#IGFBP2 BP2 IBP2%$#TRUE%$#FALSE
P01876%$#Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)%$#IGHA1%$#TRUE%$#FALSE
P01877%$#Immunoglobulin heavy constant alpha 2 (Ig alpha-2 chain C region) (Ig alpha-2 chain C region BUT) (Ig alpha-2 chain C region LAN)%$#IGHA2%$#TRUE%$#FALSE
P01859%$#Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)%$#IGHG2%$#TRUE%$#FALSE
P01860%$#Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region)%$#IGHG3%$#TRUE%$#FALSE
P01861%$#Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region)%$#IGHG4%$#TRUE%$#FALSE
P01871%$#Immunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region BOT) (Ig mu chain C region GAL) (Ig mu chain C region OU)%$#IGHM%$#TRUE%$#FALSE
A0A0C4DH31%$#Immunoglobulin heavy variable 1-18%$#IGHV1-18%$#TRUE%$#FALSE
P23083%$#Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35)%$#IGHV1-2%$#TRUE%$#FALSE
P01743%$#Immunoglobulin heavy variable 1-46 (Ig heavy chain V-I region DOT) (Ig heavy chain V-I region HG3) (Ig heavy chain V-I region Mot)%$#IGHV1-46%$#TRUE%$#FALSE
A0A0B4J1V2%$#Immunoglobulin heavy variable 2-26%$#IGHV2-26%$#TRUE%$#FALSE
A0A0C4DH43%$#Immunoglobulin heavy variable 2-70D%$#IGHV2-70D%$#TRUE%$#FALSE
A0A0B4J1V0%$#Immunoglobulin heavy variable 3-15%$#IGHV3-15%$#TRUE%$#FALSE
P01768%$#Immunoglobulin heavy variable 3-30 (Ig heavy chain V-III region BUR) (Ig heavy chain V-III region CAM) (Ig heavy chain V-III region GA) (Ig heavy chain V-III region NIE)%$#IGHV3-30%$#TRUE%$#FALSE
A0A0B4J1X8%$#Immunoglobulin heavy variable 3-43%$#IGHV3-43%$#TRUE%$#FALSE
A0A0A0MS15%$#Immunoglobulin heavy variable 3-49%$#IGHV3-49%$#TRUE%$#FALSE
A0A075B6Q5%$#Immunoglobulin heavy variable 3-64%$#IGHV3-64%$#TRUE%$#FALSE
A0A0J9YX35%$#Immunoglobulin heavy variable 3-64D%$#IGHV3-64D%$#TRUE%$#FALSE
P01780%$#Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)%$#IGHV3-7%$#TRUE%$#FALSE
A0A0B4J1Y9%$#Immunoglobulin heavy variable 3-72%$#IGHV3-72%$#TRUE%$#FALSE
A0A0B4J1V6%$#Immunoglobulin heavy variable 3-73%$#IGHV3-73%$#TRUE%$#FALSE
A0A0B4J1X5%$#Immunoglobulin heavy variable 3-74%$#IGHV3-74%$#TRUE%$#FALSE
P01782%$#Immunoglobulin heavy variable 3-9 (Ig heavy chain V-III region DOB)%$#IGHV3-9%$#TRUE%$#FALSE
A0A0C4DH34%$#Immunoglobulin heavy variable 4-28%$#IGHV4-28%$#TRUE%$#FALSE
P01824%$#Immunoglobulin heavy variable 4-39 (Ig heavy chain V-II region WAH)%$#IGHV4-39%$#TRUE%$#FALSE
A0A075B6R2%$#Immunoglobulin heavy variable 4-4%$#IGHV4-4%$#TRUE%$#FALSE
A0A0J9YXX1%$#Immunoglobulin heavy variable 5-10-1%$#IGHV5-10-1%$#TRUE%$#FALSE
A0A0C4DH38%$#Immunoglobulin heavy variable 5-51%$#IGHV5-51%$#TRUE%$#FALSE
A0A0B4J1U7%$#Immunoglobulin heavy variable 6-1%$#IGHV6-1%$#TRUE%$#FALSE
P01834%$#Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI)%$#IGKC%$#TRUE%$#FALSE
P01599%$#Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)%$#IGKV1-17%$#TRUE%$#FALSE
A0A075B6S5%$#Immunoglobulin kappa variable 1-27%$#IGKV1-27%$#TRUE%$#FALSE
P01594%$#Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)%$#IGKV1-33%$#TRUE%$#FALSE
A0A0C4DH72%$#Immunoglobulin kappa variable 1-6%$#IGKV1-6%$#TRUE%$#FALSE
A0A0C4DH68%$#Immunoglobulin kappa variable 2-24%$#IGKV2-24%$#TRUE%$#FALSE
P06310%$#Immunoglobulin kappa variable 2-30 (Ig kappa chain V-II region RPMI 6410)%$#IGKV2-30%$#TRUE%$#FALSE
A0A087WW87%$#Immunoglobulin kappa variable 2-40%$#IGKV2-40%$#TRUE%$#FALSE
A0A075B6S2%$#Immunoglobulin kappa variable 2D-29%$#IGKV2D-29%$#TRUE%$#FALSE
P01619%$#Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)%$#IGKV3-20%$#TRUE%$#FALSE
A0A0A0MRZ8%$#Immunoglobulin kappa variable 3D-11%$#IGKV3D-11%$#TRUE%$#FALSE
A0A087WSY6%$#Immunoglobulin kappa variable 3D-15%$#IGKV3D-15%$#TRUE%$#FALSE
A0A0C4DH25%$#Immunoglobulin kappa variable 3D-20%$#IGKV3D-20%$#TRUE%$#FALSE
A0A0C4DH55%$#Immunoglobulin kappa variable 3D-7%$#IGKV3D-7%$#TRUE%$#FALSE
P06312%$#Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)%$#IGKV4-1%$#TRUE%$#FALSE
A0A0C4DH24%$#Immunoglobulin kappa variable 6-21%$#IGKV6-21%$#TRUE%$#FALSE
A0A0A0MT36%$#Immunoglobulin kappa variable 6D-21%$#IGKV6D-21%$#TRUE%$#FALSE
P0DOY2%$#Immunoglobulin lambda constant 2 (Ig lambda chain C region Kern) (Ig lambda chain C region NIG-64) (Ig lambda chain C region SH) (Ig lambda chain C region X) (Ig lambda-2 chain C region)%$#IGLC2%$#TRUE%$#FALSE
P15814%$#Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)%$#IGLL1 IGL1%$#TRUE%$#FALSE
P01700%$#Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)%$#IGLV1-47%$#TRUE%$#FALSE
P01701%$#Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64)%$#IGLV1-51%$#TRUE%$#FALSE
A0A075B6I4%$#Immunoglobulin lambda variable 10-54%$#IGLV10-54%$#TRUE%$#FALSE
P01706%$#Immunoglobulin lambda variable 2-11 (Ig gamma lambda chain V-II region DOT) (Ig lambda chain V-II region BOH) (Ig lambda chain V-II region BUR) (Ig lambda chain V-II region NIG-58) (Ig lambda chain V-II region TRO) (Ig lambda chain V-II region WIN)%$#IGLV2-11%$#TRUE%$#FALSE
P01704%$#Immunoglobulin lambda variable 2-14 (Ig lambda chain V-II region NIG-84) (Ig lambda chain V-II region TOG) (Ig lambda chain V-II region VIL)%$#IGLV2-14%$#TRUE%$#FALSE
A0A075B6J9%$#Immunoglobulin lambda variable 2-18%$#IGLV2-18%$#TRUE%$#FALSE
P01705%$#Immunoglobulin lambda variable 2-23 (Ig lambda chain V-II region NEI)%$#IGLV2-23%$#TRUE%$#FALSE
P01709%$#Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)%$#IGLV2-8%$#TRUE%$#FALSE
A0A075B6K4%$#Immunoglobulin lambda variable 3-10%$#IGLV3-10%$#TRUE%$#FALSE
P01714%$#Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)%$#IGLV3-19%$#TRUE%$#FALSE
P01718%$#Immunoglobulin lambda variable 3-27 (Ig lambda chain V-IV region Kern)%$#IGLV3-27%$#TRUE%$#FALSE
A0A075B6K5%$#Immunoglobulin lambda variable 3-9%$#IGLV3-9%$#TRUE%$#FALSE
A0A075B6H9%$#Immunoglobulin lambda variable 4-69%$#IGLV4-69%$#TRUE%$#FALSE
P01721%$#Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)%$#IGLV6-57%$#TRUE%$#FALSE
P04211%$#Immunoglobulin lambda variable 7-43 (Ig lambda chain V region 4A)%$#IGLV7-43%$#TRUE%$#FALSE
A0A075B6I9%$#Immunoglobulin lambda variable 7-46%$#IGLV7-46%$#TRUE%$#FALSE
A0A075B6I0%$#Immunoglobulin lambda variable 8-61%$#IGLV8-61%$#TRUE%$#FALSE
A0A0B4J1Y8%$#Immunoglobulin lambda variable 9-49%$#IGLV9-49%$#TRUE%$#FALSE
Q969P0%$#Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316)%$#IGSF8 CD81P3 EWI2 KCT4%$#TRUE%$#FALSE
Q9UHD0%$#Interleukin-19 (IL-19) (Melanoma differentiation-associated protein-like protein) (NG.1)%$#IL19 ZMDA1%$#TRUE%$#FALSE
P46940%$#Ras GTPase-activating-like protein IQGAP1 (p195)%$#IQGAP1 KIAA0051%$#TRUE%$#FALSE
Q13576%$#Ras GTPase-activating-like protein IQGAP2%$#IQGAP2%$#TRUE%$#FALSE
Q96CN7%$#Isochorismatase domain-containing protein 1%$#ISOC1 CGI-111%$#TRUE%$#FALSE
P53990%$#IST1 homolog (hIST1) (Putative MAPK-activating protein PM28)%$#IST1 KIAA0174%$#TRUE%$#TRUE
P11215%$#Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)%$#ITGAM CD11B CR3A%$#TRUE%$#FALSE
P05107%$#Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)%$#ITGB2 CD18 MFI7%$#TRUE%$#FALSE
P19827%$#Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)%$#ITIH1 IGHEP1%$#TRUE%$#FALSE
P19823%$#Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)%$#ITIH2 IGHEP2%$#TRUE%$#FALSE
Q06033%$#Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP)%$#ITIH3%$#TRUE%$#FALSE
Q14624%$#Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]%$#ITIH4 IHRP ITIHL1 PK120 PRO1851%$#TRUE%$#FALSE
P01591%$#Immunoglobulin J chain (Joining chain of multimeric IgA and IgM)%$#JCHAIN IGCJ IGJ%$#TRUE%$#FALSE
Q9H910%$#Jupiter microtubule associated homolog 2 (Hematological and neurological expressed 1-like protein) (HN1-like protein)%$#JPT2 C16orf34 HN1L L11%$#FALSE%$#TRUE
Q15046%$#Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)%$#KARS KIAA0070%$#TRUE%$#FALSE
Q9BQ13%$#BTB/POZ domain-containing protein KCTD14%$#KCTD14%$#TRUE%$#FALSE
Q8IZA0%$#Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR)%$#KIAA0319L AAVR KIAA1837 PP791%$#TRUE%$#FALSE
Q5T5P2%$#Sickle tail protein homolog%$#KIAA1217 SKT%$#FALSE%$#TRUE
P33176%$#Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC)%$#KIF5B KNS KNS1%$#TRUE%$#FALSE
Q92876%$#Kallikrein-6 (EC 3.4.21.-) (Neurosin) (Protease M) (SP59) (Serine protease 18) (Serine protease 9) (Zyme)%$#KLK6 PRSS18 PRSS9%$#TRUE%$#FALSE
O60259%$#Kallikrein-8 (hK8) (EC 3.4.21.118) (Neuropsin) (NP) (Ovasin) (Serine protease 19) (Serine protease TADG-14) (Tumor-associated differentially expressed gene 14 protein)%$#KLK8 NRPN PRSS19 TADG14 UNQ283/PRO322%$#TRUE%$#FALSE
Q9UMN6%$#Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)%$#KMT2B HRX2 KIAA0304 MLL2 MLL4 TRX2 WBP7%$#FALSE%$#TRUE
P01042%$#Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]%$#KNG1 BDK KNG%$#TRUE%$#FALSE
Q14974%$#Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)%$#KPNB1 NTF97%$#TRUE%$#FALSE
P01116%$#GTPase KRas (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]%$#KRAS KRAS2 RASK2%$#TRUE%$#FALSE
P00709%$#Alpha-lactalbumin (Lactose synthase B protein) (Lysozyme-like protein 7)%$#LALBA LYZL7%$#TRUE%$#FALSE
P11279%$#Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a)%$#LAMP1%$#TRUE%$#FALSE
P13473%$#Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)%$#LAMP2%$#TRUE%$#FALSE
O43813%$#Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)%$#LANCL1 GPR69A%$#TRUE%$#FALSE
P28838%$#Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)%$#LAP3 LAPEP PEPS%$#TRUE%$#FALSE
Q14847%$#LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50)%$#LASP1 MLN50%$#TRUE%$#FALSE
Q14739%$#Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase)%$#LBR%$#TRUE%$#FALSE
P80188%$#Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin) (p25)%$#LCN2 HNL NGAL%$#TRUE%$#FALSE
P13796%$#Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1)%$#LCP1 PLS2%$#TRUE%$#FALSE
Q9H6V9%$#Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase) (hLDAH)%$#LDAH C2orf43%$#TRUE%$#FALSE
P00338%$#L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)%$#LDHA PIG19%$#TRUE%$#FALSE
P07195%$#L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)%$#LDHB%$#TRUE%$#FALSE
Q8NES3%$#Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)%$#LFNG%$#FALSE%$#TRUE
P09382%$#Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1)%$#LGALS1%$#TRUE%$#FALSE
P17931%$#Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)%$#LGALS3 MAC2%$#TRUE%$#FALSE
Q08380%$#Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K)%$#LGALS3BP M2BP%$#TRUE%$#FALSE
P47929%$#Galectin-7 (Gal-7) (HKL-14) (PI7) (p53-induced gene 1 protein)%$#LGALS7 PIG1; LGALS7B%$#TRUE%$#FALSE
O00182%$#Galectin-9 (Gal-9) (Ecalectin) (Tumor antigen HOM-HD-21)%$#LGALS9%$#TRUE%$#FALSE
Q99538%$#Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)%$#LGMN PRSC1%$#TRUE%$#FALSE
Q6ZUX7%$#LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein)%$#LHFPL2 KIAA0206%$#TRUE%$#FALSE
P49257%$#Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)%$#LMAN1 ERGIC53 F5F8D%$#TRUE%$#FALSE
Q12907%$#Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36)%$#LMAN2 C5orf8%$#TRUE%$#FALSE
P02545%$#Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)]%$#LMNA LMN1%$#TRUE%$#FALSE
P20700%$#Lamin-B1%$#LMNB1 LMN2 LMNB%$#TRUE%$#FALSE
Q6P5Q4%$#Leiomodin-2 (Cardiac leiomodin) (C-LMOD) (Leiomodin)%$#LMOD2%$#FALSE%$#TRUE
Q9Y4K0%$#Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14)%$#LOXL2%$#TRUE%$#FALSE
P06858%$#Lipoprotein lipase (LPL) (EC 3.1.1.34)%$#LPL LIPD%$#TRUE%$#TRUE
P22079%$#Lactoperoxidase (LPO) (EC 1.11.1.7) (Salivary peroxidase) (SPO)%$#LPO SAPX%$#TRUE%$#TRUE
P02750%$#Leucine-rich alpha-2-glycoprotein (LRG)%$#LRG1 LRG%$#TRUE%$#FALSE
Q2I0M4%$#Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer)%$#LRRC26 CAPC%$#TRUE%$#TRUE
Q96AG4%$#Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]%$#LRRC59 PRO1855%$#TRUE%$#FALSE
P33241%$#Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein) (pp52) (Lymphocyte-specific antigen WP34)%$#LSP1 WP34%$#TRUE%$#TRUE
Q86X29%$#Lipolysis-stimulated lipoprotein receptor%$#LSR LISCH%$#TRUE%$#TRUE
P48449%$#Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC)%$#LSS OSC%$#TRUE%$#FALSE
P09960%$#Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase)%$#LTA4H LTA4%$#TRUE%$#FALSE
Q14766%$#Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1)%$#LTBP1%$#TRUE%$#FALSE
P02788%$#Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C]%$#LTF GIG12 LF%$#TRUE%$#TRUE
P51884%$#Lumican (Keratan sulfate proteoglycan lumican) (KSPG lumican)%$#LUM LDC SLRR2D%$#TRUE%$#FALSE
Q14210%$#Lymphocyte antigen 6D (Ly-6D) (E48 antigen)%$#LY6D E48%$#TRUE%$#FALSE
Q9Y6Y9%$#Lymphocyte antigen 96 (Ly-96) (ESOP-1) (Protein MD-2)%$#LY96 ESOP1 MD2%$#TRUE%$#FALSE
P07948%$#Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)%$#LYN JTK8%$#TRUE%$#FALSE
P0DP58%$#Ly-6/neurotoxin-like protein 1 (Endogenous prototoxin LYNX1) (Testicular tissue protein Li 112)%$#LYNX1%$#TRUE%$#FALSE
O95274%$#Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein) (MIG-C4)%$#LYPD3 C4.4A UNQ491/PRO1007%$#TRUE%$#FALSE
O95372%$#Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II)%$#LYPLA2 APT2%$#TRUE%$#FALSE
P61626%$#Lysozyme C (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C)%$#LYZ LZM%$#TRUE%$#FALSE
P33908%$#Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Man9-mannosidase) (Mannosidase alpha class 1A member 1) (Processing alpha-1,2-mannosidase IA) (Alpha-1,2-mannosidase IA)%$#MAN1A1%$#TRUE%$#FALSE
O00462%$#Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)%$#MANBA MANB1%$#TRUE%$#FALSE
P55145%$#Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET)%$#MANF ARMET ARP%$#TRUE%$#FALSE
Q02750%$#Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1)%$#MAP2K1 MEK1 PRKMK1%$#TRUE%$#FALSE
P28482%$#Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)%$#MAPK1 ERK2 PRKM1 PRKM2%$#TRUE%$#FALSE
O15264%$#Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4)%$#MAPK13 PRKM13 SAPK4%$#TRUE%$#FALSE
Q8NDC0%$#MAPK-interacting and spindle-stabilizing protein-like (Mitogen-activated protein kinase 1-interacting protein 1-like)%$#MAPK1IP1L C14orf32%$#FALSE%$#TRUE
Q15691%$#Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1)%$#MAPRE1%$#TRUE%$#FALSE
P29966%$#Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)%$#MARCKS MACS PRKCSL%$#TRUE%$#FALSE
P49006%$#MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS)%$#MARCKSL1 MLP MRP%$#TRUE%$#TRUE
P56192%$#Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)%$#MARS%$#TRUE%$#FALSE
O00339%$#Matrilin-2%$#MATN2 UNQ193/PRO219%$#TRUE%$#FALSE
O15232%$#Matrilin-3%$#MATN3%$#TRUE%$#TRUE
Q8NI22%$#Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein)%$#MCFD2 SDNSF%$#FALSE%$#TRUE
P40925%$#Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)%$#MDH1 MDHA%$#TRUE%$#FALSE
P40926%$#Malate dehydrogenase, mitochondrial (EC 1.1.1.37)%$#MDH2%$#TRUE%$#FALSE
P21741%$#Midkine (MK) (Amphiregulin-associated protein) (ARAP) (Midgestation and kidney protein) (Neurite outgrowth-promoting factor 2) (Neurite outgrowth-promoting protein)%$#MDK MK1 NEGF2%$#TRUE%$#FALSE
Q14696%$#LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61)%$#MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369%$#TRUE%$#FALSE
Q9H8H3%$#Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B)%$#METTL7A PRO0066 UNQ1902/PRO4348%$#TRUE%$#TRUE
P55001%$#Microfibrillar-associated protein 2 (MFAP-2) (Microfibril-associated glycoprotein 1) (MAGP) (MAGP-1)%$#MFAP2 MAGP1%$#TRUE%$#FALSE
Q08431%$#Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin]%$#MFGE8%$#TRUE%$#FALSE
P26572%$#Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)%$#MGAT1 GGNT1 GLCT1 GLYT1 MGAT%$#TRUE%$#FALSE
P08493%$#Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein)%$#MGP MGLAP GIG36%$#TRUE%$#FALSE
P10620%$#Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I)%$#MGST1 GST12 MGST%$#TRUE%$#FALSE
Q99735%$#Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Microsomal GST-II)%$#MGST2 GST2%$#TRUE%$#FALSE
P14174%$#Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)%$#MIF GLIF MMIF%$#TRUE%$#FALSE
Q9UNW1%$#Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)%$#MINPP1 MIPP UNQ900/PRO1917%$#TRUE%$#FALSE
Q14165%$#Malectin%$#MLEC KIAA0152%$#TRUE%$#FALSE
P09237%$#Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase)%$#MMP7 MPSL1 PUMP1%$#TRUE%$#FALSE
P22894%$#Neutrophil collagenase (EC 3.4.24.34) (Matrix metalloproteinase-8) (MMP-8) (PMNL collagenase) (PMNL-CL)%$#MMP8 CLG1%$#TRUE%$#TRUE
P14780%$#Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]%$#MMP9 CLG4B%$#TRUE%$#FALSE
P41218%$#Myeloid cell nuclear differentiation antigen%$#MNDA%$#TRUE%$#TRUE
Q7L9L4%$#MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A)%$#MOB1B MOB4A MOBKL1A%$#TRUE%$#FALSE
P05164%$#Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain]%$#MPO%$#TRUE%$#FALSE
Q8N3R9%$#MAGUK p55 subfamily member 5%$#MPP5 PALS1%$#TRUE%$#FALSE
P22897%$#Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)%$#MRC1 CLEC13D CLEC13DL MRC1L1%$#TRUE%$#TRUE
Q96HJ5%$#Membrane-spanning 4-domains subfamily A member 3 (CD20 antigen-like protein) (Hematopoietic-specific transmembrane protein 4) (HTm4)%$#MS4A3 CD20L HTM4%$#FALSE%$#TRUE
P26038%$#Moesin (Membrane-organizing extension spike protein)%$#MSN%$#TRUE%$#TRUE
Q13126%$#S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)%$#MTAP MSAP%$#TRUE%$#FALSE
P11586%$#C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]%$#MTHFD1 MTHFC MTHFD%$#TRUE%$#FALSE
P15941%$#Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]%$#MUC1 PUM%$#TRUE%$#TRUE
Q8N387%$#Mucin-15 (MUC-15)%$#MUC15 UNQ750/PRO1481%$#FALSE%$#TRUE
Q99102%$#Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)]%$#MUC4%$#TRUE%$#FALSE
P53602%$#Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase)%$#MVD MPD%$#TRUE%$#FALSE
Q14764%$#Major vault protein (MVP) (Lung resistance-related protein)%$#MVP LRP%$#TRUE%$#FALSE
Q96S97%$#Myeloid-associated differentiation marker (Protein SB135)%$#MYADM UNQ553/PRO1110%$#TRUE%$#TRUE
Q969H8%$#Myeloid-derived growth factor (MYDGF)%$#MYDGF C19orf10%$#TRUE%$#FALSE
P35579%$#Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)%$#MYH9%$#TRUE%$#FALSE
O14950%$#Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)%$#MYL12B MRLC2 MYLC2B%$#TRUE%$#FALSE
P60660%$#Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6)%$#MYL6%$#TRUE%$#FALSE
O00159%$#Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)%$#MYO1C%$#TRUE%$#FALSE
O94832%$#Unconventional myosin-Id%$#MYO1D KIAA0727%$#TRUE%$#FALSE
O00160%$#Unconventional myosin-If (Myosin-Ie)%$#MYO1F%$#TRUE%$#FALSE
Q9UM54%$#Unconventional myosin-VI (Unconventional myosin-6)%$#MYO6 KIAA0389%$#TRUE%$#FALSE
Q9NZM1%$#Myoferlin (Fer-1-like protein 3)%$#MYOF FER1L3 KIAA1207%$#TRUE%$#FALSE
E9PAV3%$#Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC)%$#NACA%$#TRUE%$#FALSE
Q9UJ70%$#N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase)%$#NAGK%$#TRUE%$#FALSE
P54802%$#Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]%$#NAGLU UFHSD1%$#TRUE%$#FALSE
P43490%$#Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin)%$#NAMPT PBEF PBEF1%$#TRUE%$#FALSE
Q9NR45%$#Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)%$#NANS SAS%$#TRUE%$#FALSE
P54920%$#Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha)%$#NAPA SNAPA%$#TRUE%$#FALSE
Q99747%$#Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma)%$#NAPG SNAPG%$#TRUE%$#FALSE
O43776%$#Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)%$#NARS%$#TRUE%$#FALSE
Q6ZVX7%$#F-box only protein 50 (NCC receptor protein 1 homolog) (NCCRP-1) (Non-specific cytotoxic cell receptor protein 1 homolog)%$#NCCRP1 FBXO50%$#TRUE%$#FALSE
A6NI72%$#Putative neutrophil cytosol factor 1B (NCF-1B) (Putative SH3 and PX domain-containing protein 1B)%$#NCF1B SH3PXD1B%$#TRUE%$#TRUE
P19878%$#Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)%$#NCF2 NOXA2 P67PHOX%$#TRUE%$#FALSE
Q68D85%$#Natural cytotoxicity triggering receptor 3 ligand 1 (B7 homolog 6) (B7-H6)%$#NCR3LG1 B7H6%$#TRUE%$#FALSE
Q92597%$#Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42)%$#NDRG1 CAP43 DRG1 RTP%$#TRUE%$#TRUE
Q9UN36%$#Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613)%$#NDRG2 KIAA1248 SYLD%$#TRUE%$#TRUE
O00483%$#Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit)%$#NDUFA4%$#FALSE%$#TRUE
Q99519%$#Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1)%$#NEU1 NANH%$#TRUE%$#FALSE
Q96TA1%$#Protein Niban 2 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Niban-like protein 1) (Protein FAM129B)%$#NIBAN2 C9orf88 FAM129B%$#TRUE%$#TRUE
P14543%$#Nidogen-1 (NID-1) (Entactin)%$#NID1 NID%$#TRUE%$#FALSE
Q9NQR4%$#Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2)%$#NIT2 CUA002%$#TRUE%$#FALSE
P15531%$#Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)%$#NME1 NDPKA NM23%$#TRUE%$#FALSE
P22392%$#Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2)%$#NME2 NM23B%$#TRUE%$#FALSE
Q13232%$#Nucleoside diphosphate kinase 3 (NDK 3) (NDP kinase 3) (EC 2.7.4.6) (DR-nm23) (Nucleoside diphosphate kinase C) (NDPKC) (nm23-H3)%$#NME3%$#TRUE%$#FALSE
P30419%$#Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1)%$#NMT1 NMT%$#TRUE%$#FALSE
P61916%$#NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein)%$#NPC2 HE1%$#TRUE%$#FALSE
P55786%$#Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)%$#NPEPPS PSA%$#TRUE%$#FALSE
P06748%$#Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)%$#NPM1 NPM%$#TRUE%$#FALSE
Q6UXI9%$#Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like)%$#NPNT EGFL6L POEM UNQ295/PRO334%$#TRUE%$#FALSE
Q9Y639%$#Neuroplastin (Stromal cell-derived receptor 1) (SDR-1)%$#NPTN SDFR1 SDR1%$#TRUE%$#FALSE
O14786%$#Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304)%$#NRP1 NRP VEGF165R%$#TRUE%$#FALSE
Q15738%$#Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) (Protein H105e3)%$#NSDHL H105E3%$#TRUE%$#TRUE
P46459%$#Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)%$#NSF%$#TRUE%$#FALSE
Q9UNZ2%$#NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47)%$#NSFL1C UBXN2C%$#TRUE%$#FALSE
P49902%$#Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)%$#NT5C2 NT5B NT5CP PNT5%$#TRUE%$#FALSE
Q02818%$#Nucleobindin-1 (CALNUC)%$#NUCB1 NUC%$#TRUE%$#FALSE
P80303%$#Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1]%$#NUCB2 NEFA%$#TRUE%$#FALSE
Q9UKK9%$#ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (hNUDT5) (YSA1H)%$#NUDT5 NUDIX5 HSPC115%$#TRUE%$#FALSE
P61970%$#Nuclear transport factor 2 (NTF-2) (Placental protein 15) (PP15)%$#NUTF2 NTF2%$#TRUE%$#FALSE
Q9NV23%$#S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Augmented in rheumatoid arthritis 1) (AURA1) (Oleoyl-ACP hydrolase) (Thioesterase 2) (TE2) (Thioesterase II) (Thioesterase domain-containing protein 1)%$#OLAH THEDC1%$#TRUE%$#FALSE
Q6UX06%$#Olfactomedin-4 (OLM4) (Antiapoptotic protein GW112) (G-CSF-stimulated clone 1 protein) (hGC-1) (hOLfD)%$#OLFM4 GW112 UNQ362/PRO698%$#TRUE%$#TRUE
Q96D31%$#Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A)%$#ORAI1 CRACM1 TMEM142A%$#TRUE%$#FALSE
P02763%$#Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1)%$#ORM1 AGP1%$#TRUE%$#FALSE
P19652%$#Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2)%$#ORM2 AGP2%$#TRUE%$#FALSE
Q13438%$#Protein OS-9 (Amplified in osteosarcoma 9)%$#OS9%$#TRUE%$#TRUE
P22059%$#Oxysterol-binding protein 1%$#OSBP OSBP1%$#FALSE%$#TRUE
Q969R2%$#Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4) (ORP-4) (OSBP-related protein 4)%$#OSBP2 KIAA1664 ORP4 OSBPL4%$#TRUE%$#FALSE
Q99650%$#Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB)%$#OSMR OSMRB%$#TRUE%$#FALSE
Q9NRP0%$#Oligosaccharyltransferase complex subunit OSTC (Hydrophobic protein HSF-28)%$#OSTC DC2 HDCMD45P HSPC307%$#TRUE%$#FALSE
Q92882%$#Osteoclast-stimulating factor 1%$#OSTF1%$#TRUE%$#FALSE
Q96FW1%$#Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1)%$#OTUB1 OTB1 OTU1 HSPC263%$#TRUE%$#FALSE
P07237%$#Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)%$#P4HB ERBA2L PDI PDIA1 PO4DB%$#TRUE%$#FALSE
Q9UQ80%$#Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1)%$#PA2G4 EBP1%$#TRUE%$#FALSE
P11940%$#Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)%$#PABPC1 PAB1 PABP1 PABPC2%$#TRUE%$#FALSE
Q13310%$#Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP)%$#PABPC4 APP1 PABP4%$#TRUE%$#FALSE
Q9UNF0%$#Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II)%$#PACSIN2%$#TRUE%$#FALSE
Q9UKS6%$#Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511)%$#PACSIN3%$#TRUE%$#FALSE
Q9Y2J8%$#Protein-arginine deiminase type-2 (EC 3.5.3.15) (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II)%$#PADI2 KIAA0994 PAD2 PDI2%$#TRUE%$#FALSE
P43034%$#Platelet-activating factor acetylhydrolase IB subunit alpha (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha)%$#PAFAH1B1 LIS1 MDCR MDS PAFAHA%$#TRUE%$#FALSE
P22234%$#Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]%$#PAICS ADE2 AIRC PAIS%$#TRUE%$#FALSE
Q9H074%$#Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)%$#PAIP1%$#TRUE%$#FALSE
P19021%$#Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)]%$#PAM%$#TRUE%$#FALSE
Q99497%$#Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Oncogene DJ1) (Parkinson disease protein 7) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1)%$#PARK7%$#TRUE%$#FALSE
P61457%$#Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD)%$#PCBD1 DCOH PCBD%$#TRUE%$#FALSE
Q15365%$#Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3)%$#PCBP1%$#TRUE%$#FALSE
Q15366%$#Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2)%$#PCBP2%$#TRUE%$#FALSE
P22061%$#Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)%$#PCMT1%$#TRUE%$#FALSE
P29122%$#Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4)%$#PCSK6 PACE4%$#TRUE%$#FALSE
Q9UHG3%$#Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase)%$#PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183%$#TRUE%$#FALSE
Q9BUL8%$#Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15)%$#PDCD10 CCM3 TFAR15%$#TRUE%$#FALSE
Q53EL6%$#Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a)%$#PDCD4 H731%$#TRUE%$#FALSE
O75340%$#Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)%$#PDCD6 ALG2%$#TRUE%$#FALSE
Q8WUM4%$#Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95)%$#PDCD6IP AIP1 ALIX KIAA1375%$#TRUE%$#FALSE
P30101%$#Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)%$#PDIA3 ERP57 ERP60 GRP58%$#TRUE%$#FALSE
P13667%$#Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)%$#PDIA4 ERP70 ERP72%$#TRUE%$#FALSE
Q15084%$#Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)%$#PDIA6 ERP5 P5 TXNDC7%$#TRUE%$#FALSE
Q96HC4%$#PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein)%$#PDLIM5 ENH L9%$#TRUE%$#FALSE
O00764%$#Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)%$#PDXK C21orf124 C21orf97 PKH PNK PRED79%$#TRUE%$#FALSE
Q13113%$#PDZK1-interacting protein 1 (17 kDa membrane-associated protein) (Protein DD96)%$#PDZK1IP1 MAP17%$#TRUE%$#TRUE
P30086%$#Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)]%$#PEBP1 PBP PEBP%$#TRUE%$#FALSE
P17858%$#ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)%$#PFKL%$#TRUE%$#FALSE
P07737%$#Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)%$#PFN1%$#TRUE%$#FALSE
P18669%$#Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)%$#PGAM1 PGAMA CDABP0006%$#TRUE%$#FALSE
P52209%$#6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)%$#PGD PGDH%$#TRUE%$#FALSE
P00558%$#Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)%$#PGK1 PGKA MIG10 OK/SW-cl.110%$#TRUE%$#FALSE
O75594%$#Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S)%$#PGLYRP1 PGLYRP PGRP TNFSF3L SBBI68 UNQ639/PRO1269%$#TRUE%$#FALSE
Q96PD5%$#N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L)%$#PGLYRP2 PGLYRPL PGRPL UNQ3103/PRO10102%$#TRUE%$#FALSE
P36871%$#Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)%$#PGM1%$#TRUE%$#FALSE
Q96G03%$#Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7)%$#PGM2 MSTP006%$#TRUE%$#FALSE
O95394%$#Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)%$#PGM3 AGM1%$#TRUE%$#FALSE
O00264%$#Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA)%$#PGRMC1 HPR6.6 PGRMC%$#TRUE%$#TRUE
P35232%$#Prohibitin%$#PHB%$#TRUE%$#FALSE
Q99623%$#Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)%$#PHB2 BAP REA%$#TRUE%$#FALSE
O43175%$#D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37)%$#PHGDH PGDH3%$#TRUE%$#FALSE
Q9NRX4%$#14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP) (Protein janus-A homolog)%$#PHPT1 PHP14 CGI-202 HSPC141%$#TRUE%$#FALSE
Q13492%$#Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein)%$#PICALM CALM%$#TRUE%$#FALSE
P01833%$#Polymeric immunoglobulin receptor (PIgR) (Poly-Ig receptor) (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component]%$#PIGR%$#TRUE%$#TRUE
Q9Y237%$#Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (hPar14) (Parvulin-17) (Par17) (hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH) (hEPVH) (Rotamase Pin4)%$#PIN4%$#TRUE%$#FALSE
P12273%$#Prolactin-inducible protein (Gross cystic disease fluid protein 15) (GCDFP-15) (Prolactin-induced protein) (Secretory actin-binding protein) (SABP) (gp17)%$#PIP GCDFP15 GPIP4%$#TRUE%$#FALSE
Q8TBX8%$#Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma)%$#PIP4K2C PIP5K2C%$#TRUE%$#FALSE
Q00169%$#Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)%$#PITPNA PITPN%$#TRUE%$#FALSE
P48739%$#Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta)%$#PITPNB%$#TRUE%$#FALSE
P14618%$#Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)%$#PKM OIP3 PK2 PK3 PKM2%$#TRUE%$#TRUE
Q9NZ20%$#Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)%$#PLA2G3%$#TRUE%$#FALSE
Q03405%$#Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87)%$#PLAUR MO3 UPAR%$#TRUE%$#FALSE
Q6P4A8%$#Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C]%$#PLBD1%$#TRUE%$#FALSE
P00747%$#Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]%$#PLG%$#TRUE%$#TRUE
Q99541%$#Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP)%$#PLIN2 ADFP%$#TRUE%$#TRUE
O60664%$#Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17)%$#PLIN3 M6PRBP1 TIP47%$#TRUE%$#TRUE
Q02809%$#Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)%$#PLOD1 LLH PLOD%$#TRUE%$#FALSE
O60568%$#Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]%$#PLOD3%$#TRUE%$#FALSE
P55058%$#Phospholipid transfer protein (Lipid transfer protein II)%$#PLTP%$#TRUE%$#FALSE
Q6UX71%$#Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)%$#PLXDC2 TEM7R UNQ2514/PRO6003%$#FALSE%$#TRUE
O15305%$#Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8)%$#PMM2%$#TRUE%$#FALSE
P00491%$#Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase)%$#PNP NP%$#TRUE%$#FALSE
Q96AD5%$#Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2) (Desnutrin) (IPLA2-zeta) (Pigment epithelium-derived factor) (TTS2.2) (Transport-secretion protein 2) (TTS2)%$#PNPLA2 ATGL FP17548%$#FALSE%$#TRUE
O00592%$#Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1)%$#PODXL PCLP PCLP1%$#TRUE%$#TRUE
P27169%$#Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)%$#PON1 PON%$#TRUE%$#FALSE
Q15063%$#Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)%$#POSTN OSF2%$#TRUE%$#FALSE
Q6S8J3%$#POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2) (POTE-2)%$#POTEE A26C1A POTE2%$#TRUE%$#FALSE
Q15181%$#Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase)%$#PPA1 IOPPP PP%$#TRUE%$#FALSE
P62937%$#Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]%$#PPIA CYPA%$#TRUE%$#FALSE
P23284%$#Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)%$#PPIB CYPB%$#TRUE%$#FALSE
P45877%$#Peptidyl-prolyl cis-trans isomerase C (PPIase C) (EC 5.2.1.8) (Cyclophilin C) (Rotamase C)%$#PPIC CYPC%$#TRUE%$#FALSE
P62140%$#Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53)%$#PPP1CB%$#TRUE%$#FALSE
Q15435%$#Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22)%$#PPP1R7 SDS22%$#TRUE%$#FALSE
P30153%$#Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)%$#PPP2R1A%$#TRUE%$#FALSE
Q08209%$#Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform)%$#PPP3CA CALNA CNA%$#TRUE%$#FALSE
P50897%$#Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)%$#PPT1 CLN1 PPT%$#TRUE%$#FALSE
P42785%$#Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP)%$#PRCP PCP%$#TRUE%$#FALSE
Q06830%$#Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2)%$#PRDX1 PAGA PAGB TDPX2%$#TRUE%$#FALSE
P32119%$#Peroxiredoxin-2 (EC 1.11.1.15) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1)%$#PRDX2 NKEFB TDPX1%$#TRUE%$#FALSE
P30048%$#Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog)%$#PRDX3 AOP1%$#TRUE%$#FALSE
Q13162%$#Peroxiredoxin-4 (EC 1.11.1.15) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372)%$#PRDX4%$#TRUE%$#FALSE
P30044%$#Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)%$#PRDX5 ACR1 SBBI10%$#TRUE%$#FALSE
P30041%$#Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)%$#PRDX6 AOP2 KIAA0106%$#TRUE%$#FALSE
P13727%$#Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]%$#PRG2 MBP%$#TRUE%$#FALSE
Q9Y2Y8%$#Proteoglycan 3 (Eosinophil major basic protein homolog) (Prepro-major basic protein homolog) (Prepro-MBPH)%$#PRG3 MBPH UNQ486/PRO1002%$#TRUE%$#FALSE
P17612%$#cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)%$#PRKACA PKACA%$#TRUE%$#FALSE
P10644%$#cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1)%$#PRKAR1A PKR1 PRKAR1 TSE1%$#TRUE%$#FALSE
P13861%$#cAMP-dependent protein kinase type II-alpha regulatory subunit%$#PRKAR2A PKR2 PRKAR2%$#TRUE%$#FALSE
Q04759%$#Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)%$#PRKCQ PRKCT%$#TRUE%$#FALSE
P14314%$#Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)%$#PRKCSH G19P1%$#TRUE%$#FALSE
O75569%$#Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)%$#PRKRA PACT RAX HSD-14 HSD14%$#TRUE%$#FALSE
O43490%$#Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133)%$#PROM1 PROML1 MSTP061%$#TRUE%$#FALSE
P11908%$#Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II)%$#PRPS2%$#TRUE%$#FALSE
Q96M27%$#Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1)%$#PRRC1%$#TRUE%$#FALSE
O14669%$#Transmembrane gamma-carboxyglutamic acid protein 2 (Proline-rich gamma-carboxyglutamic acid protein 2) (Proline-rich Gla protein 2)%$#PRRG2 PRGP2 TMG2%$#FALSE%$#TRUE
P07477%$#Trypsin-1 (EC 3.4.21.4) (Beta-trypsin) (Cationic trypsinogen) (Serine protease 1) (Trypsin I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]%$#PRSS1 TRP1 TRY1 TRYP1%$#TRUE%$#FALSE
Q9GZN4%$#Brain-specific serine protease 4 (BSSP-4) (EC 3.4.21.-) (Serine protease 22) (Serine protease 26) (Tryptase epsilon)%$#PRSS22 BSSP4 PRSS26 SP001LA UNQ302/PRO343%$#FALSE%$#TRUE
Q16651%$#Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]%$#PRSS8%$#TRUE%$#FALSE
P24158%$#Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)%$#PRTN3 MBN%$#TRUE%$#FALSE
P07602%$#Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]%$#PSAP GLBA SAP1%$#TRUE%$#FALSE
Q16557%$#Pregnancy-specific beta-1-glycoprotein 3 (PS-beta-G-3) (PSBG-3) (Pregnancy-specific glycoprotein 3) (Carcinoembryonic antigen SG5)%$#PSG3%$#TRUE%$#FALSE
P25786%$#Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)%$#PSMA1 HC2 NU PROS30 PSC2%$#TRUE%$#FALSE
P25788%$#Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)%$#PSMA3 HC8 PSC8%$#TRUE%$#FALSE
P25789%$#Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)%$#PSMA4 HC9 PSC9%$#TRUE%$#FALSE
P28066%$#Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain)%$#PSMA5%$#TRUE%$#FALSE
P60900%$#Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)%$#PSMA6 PROS27%$#TRUE%$#FALSE
O14818%$#Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)%$#PSMA7 HSPC%$#TRUE%$#FALSE
P20618%$#Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)%$#PSMB1 PSC5%$#TRUE%$#FALSE
P49721%$#Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)%$#PSMB2%$#TRUE%$#FALSE
P49720%$#Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)%$#PSMB3%$#TRUE%$#FALSE
P28070%$#Proteasome subunit beta type-4 (EC 3.4.25.1) (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3)%$#PSMB4 PROS26%$#TRUE%$#FALSE
P28072%$#Proteasome subunit beta type-6 (EC 3.4.25.1) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y)%$#PSMB6 LMPY Y%$#TRUE%$#FALSE
Q99436%$#Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z)%$#PSMB7 Z%$#TRUE%$#FALSE
P28062%$#Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein)%$#PSMB8 LMP7 PSMB5i RING10 Y2%$#TRUE%$#FALSE
P35998%$#26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1)%$#PSMC2 MSS1%$#TRUE%$#FALSE
P62195%$#26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG)%$#PSMC5 SUG1%$#TRUE%$#FALSE
Q99460%$#26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112)%$#PSMD1%$#TRUE%$#FALSE
O00231%$#26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5)%$#PSMD11%$#TRUE%$#FALSE
Q9UNM6%$#26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5)%$#PSMD13%$#TRUE%$#FALSE
Q13200%$#26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2)%$#PSMD2 TRAP2%$#TRUE%$#FALSE
Q15008%$#26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)%$#PSMD6 KIAA0107 PFAAP4%$#TRUE%$#FALSE
Q06323%$#Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha)%$#PSME1 IFI5111%$#TRUE%$#FALSE
Q9UL46%$#Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta)%$#PSME2%$#TRUE%$#FALSE
P26599%$#Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)%$#PTBP1 PTB%$#FALSE%$#TRUE
Q15185%$#Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23)%$#PTGES3 P23 TEBP%$#TRUE%$#FALSE
Q14914%$#Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74)%$#PTGR1 LTB4DH%$#TRUE%$#FALSE
P12272%$#Parathyroid hormone-related protein (PTH-rP) (PTHrP) (Parathyroid hormone-like protein) (PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139])]%$#PTHLH PTHRP%$#TRUE%$#TRUE
P06454%$#Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed; Thymosin alpha-1]%$#PTMA TMSA%$#TRUE%$#TRUE
Q99952%$#Tyrosine-protein phosphatase non-receptor type 18 (EC 3.1.3.48) (Brain-derived phosphatase)%$#PTPN18 BDP1%$#FALSE%$#TRUE
P29350%$#Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)%$#PTPN6 HCP PTP1C%$#TRUE%$#FALSE
P08575%$#Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)%$#PTPRC CD45%$#TRUE%$#FALSE
P10586%$#Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)%$#PTPRF LAR%$#TRUE%$#FALSE
Q12913%$#Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148)%$#PTPRJ DEP1%$#TRUE%$#FALSE
Q15262%$#Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)%$#PTPRK PTPK%$#TRUE%$#FALSE
Q92626%$#Peroxidasin homolog (EC 1.11.1.7) (Melanoma-associated antigen MG50) (Vascular peroxidase 1) (p53-responsive gene 2 protein)%$#PXDN KIAA0230 MG50 PRG2 VPO VPO1%$#TRUE%$#TRUE
P49023%$#Paxillin%$#PXN%$#TRUE%$#FALSE
Q9ULZ3%$#Apoptosis-associated speck-like protein containing a CARD (hASC) (Caspase recruitment domain-containing protein 5) (PYD and CARD domain-containing protein) (Target of methylation-induced silencing 1)%$#PYCARD ASC CARD5 TMS1%$#TRUE%$#FALSE
P11216%$#Glycogen phosphorylase, brain form (EC 2.4.1.1)%$#PYGB%$#TRUE%$#FALSE
P06737%$#Glycogen phosphorylase, liver form (EC 2.4.1.1)%$#PYGL%$#TRUE%$#FALSE
P20742%$#Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)%$#PZP CPAMD6%$#TRUE%$#FALSE
P47897%$#Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)%$#QARS%$#TRUE%$#FALSE
P09417%$#Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)%$#QDPR DHPR SDR33C1%$#TRUE%$#FALSE
O00391%$#Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6)%$#QSOX1 QSCN6 UNQ2520/PRO6013%$#TRUE%$#TRUE
P61026%$#Ras-related protein Rab-10%$#RAB10%$#TRUE%$#FALSE
Q15907%$#Ras-related protein Rab-11B (GTP-binding protein YPT3)%$#RAB11B YPT3%$#TRUE%$#FALSE
P51153%$#Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein)%$#RAB13 GIG4%$#TRUE%$#FALSE
P61106%$#Ras-related protein Rab-14%$#RAB14%$#TRUE%$#FALSE
Q9NP72%$#Ras-related protein Rab-18%$#RAB18%$#TRUE%$#FALSE
P62820%$#Ras-related protein Rab-1A (YPT1-related protein)%$#RAB1A RAB1%$#TRUE%$#FALSE
Q9H0U4%$#Ras-related protein Rab-1B%$#RAB1B%$#TRUE%$#FALSE
Q9UL25%$#Ras-related protein Rab-21%$#RAB21 KIAA0118%$#TRUE%$#FALSE
P57735%$#Ras-related protein Rab-25 (CATX-8)%$#RAB25 CATX8%$#TRUE%$#FALSE
P51159%$#Ras-related protein Rab-27A (Rab-27) (GTP-binding protein Ram)%$#RAB27A RAB27%$#TRUE%$#FALSE
P61019%$#Ras-related protein Rab-2A%$#RAB2A RAB2%$#TRUE%$#FALSE
Q8WUD1%$#Ras-related protein Rab-2B%$#RAB2B%$#TRUE%$#FALSE
Q15286%$#Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C)%$#RAB35 RAB1C RAY%$#TRUE%$#FALSE
O95716%$#Ras-related protein Rab-3D%$#RAB3D GOV RAB16%$#TRUE%$#FALSE
P20339%$#Ras-related protein Rab-5A%$#RAB5A RAB5%$#TRUE%$#FALSE
P61020%$#Ras-related protein Rab-5B%$#RAB5B%$#TRUE%$#FALSE
P51148%$#Ras-related protein Rab-5C (L1880) (RAB5L)%$#RAB5C RABL%$#TRUE%$#FALSE
P20340%$#Ras-related protein Rab-6A (Rab-6)%$#RAB6A RAB6%$#TRUE%$#FALSE
P51149%$#Ras-related protein Rab-7a%$#RAB7A RAB7%$#TRUE%$#FALSE
P61006%$#Ras-related protein Rab-8A (Oncogene c-mel)%$#RAB8A MEL RAB8%$#TRUE%$#FALSE
Q92930%$#Ras-related protein Rab-8B%$#RAB8B%$#TRUE%$#FALSE
P63000%$#Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)%$#RAC1 TC25 MIG5%$#TRUE%$#FALSE
P15153%$#Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)%$#RAC2%$#TRUE%$#FALSE
P63244%$#Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]%$#RACK1 GNB2L1 HLC7 PIG21%$#TRUE%$#FALSE
P54725%$#UV excision repair protein RAD23 homolog A (HR23A) (hHR23A)%$#RAD23A%$#TRUE%$#FALSE
P54727%$#UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58)%$#RAD23B%$#TRUE%$#FALSE
P11233%$#Ras-related protein Ral-A%$#RALA RAL%$#TRUE%$#FALSE
P11234%$#Ras-related protein Ral-B%$#RALB%$#TRUE%$#FALSE
P62826%$#GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)%$#RAN ARA24 OK/SW-cl.81%$#TRUE%$#FALSE
P62834%$#Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)%$#RAP1A KREV1%$#TRUE%$#FALSE
P61224%$#Ras-related protein Rap-1b (GTP-binding protein smg p21B)%$#RAP1B OK/SW-cl.11%$#TRUE%$#FALSE
P61225%$#Ras-related protein Rap-2b%$#RAP2B%$#TRUE%$#FALSE
P49788%$#Retinoic acid receptor responder protein 1 (Phorbol ester-induced gene 1 protein) (PERG-1) (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein)%$#RARRES1 PEIG1 TIG1%$#TRUE%$#FALSE
P54136%$#Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)%$#RARS%$#TRUE%$#FALSE
Q8IXT5%$#RNA-binding protein 12B (RNA-binding motif protein 12B)%$#RBM12B%$#FALSE%$#TRUE
P09455%$#Retinol-binding protein 1 (Cellular retinol-binding protein) (CRBP) (Cellular retinol-binding protein I) (CRBP-I)%$#RBP1 CRBP1%$#TRUE%$#FALSE
P02753%$#Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176)]%$#RBP4 PRO2222%$#TRUE%$#FALSE
Q8TC12%$#Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)%$#RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82%$#TRUE%$#FALSE
P35241%$#Radixin%$#RDX%$#TRUE%$#TRUE
Q00765%$#Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2)%$#REEP5 C5orf18 DP1 TB2%$#TRUE%$#FALSE
Q9HD89%$#Resistin (Adipose tissue-specific secretory factor) (ADSF) (C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein) (Cysteine-rich secreted protein A12-alpha-like 2) (Cysteine-rich secreted protein FIZZ3)%$#RETN FIZZ3 HXCP1 RSTN UNQ407/PRO1199%$#TRUE%$#FALSE
Q86VR2%$#Reticulophagy regulator 3%$#RETREG3 FAM134C%$#FALSE%$#TRUE
P61586%$#Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12)%$#RHOA ARH12 ARHA RHO12%$#TRUE%$#FALSE
P84095%$#Rho-related GTP-binding protein RhoG%$#RHOG ARHG%$#TRUE%$#FALSE
P07998%$#Ribonuclease pancreatic (EC 4.6.1.18) (HP-RNase) (RIB-1) (RNase UpI-1) (Ribonuclease 1) (RNase 1) (Ribonuclease A) (RNase A)%$#RNASE1 RIB1 RNS1%$#TRUE%$#FALSE
P10153%$#Non-secretory ribonuclease (EC 4.6.1.18) (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2) (RNase 2) (Ribonuclease US)%$#RNASE2 EDN RNS2%$#TRUE%$#FALSE
P12724%$#Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)%$#RNASE3 ECP RNS3%$#TRUE%$#FALSE
P34096%$#Ribonuclease 4 (RNase 4) (EC 3.1.27.-)%$#RNASE4 RNS4%$#TRUE%$#FALSE
O00584%$#Ribonuclease T2 (EC 3.1.27.-) (Ribonuclease 6)%$#RNASET2 RNASE6PL%$#TRUE%$#FALSE
P13489%$#Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI)%$#RNH1 PRI RNH%$#TRUE%$#FALSE
Q9H4A4%$#Aminopeptidase B (AP-B) (EC 3.4.11.6) (Arginine aminopeptidase) (Arginyl aminopeptidase)%$#RNPEP APB%$#TRUE%$#FALSE
O75695%$#Protein XRP2%$#RP2%$#TRUE%$#FALSE
P27635%$#60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)%$#RPL10 DXS648E QM%$#TRUE%$#FALSE
P62906%$#60S ribosomal protein L10a (CSA-19) (Large ribosomal subunit protein uL1) (Neural precursor cell expressed developmentally down-regulated protein 6) (NEDD-6)%$#RPL10A NEDD6%$#TRUE%$#FALSE
P62913%$#60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)%$#RPL11%$#TRUE%$#FALSE
P30050%$#60S ribosomal protein L12 (Large ribosomal subunit protein uL11)%$#RPL12%$#TRUE%$#FALSE
P26373%$#60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)%$#RPL13 BBC1 OK/SW-cl.46%$#TRUE%$#FALSE
P40429%$#60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)%$#RPL13A%$#TRUE%$#FALSE
P50914%$#60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)%$#RPL14%$#TRUE%$#FALSE
P61313%$#60S ribosomal protein L15 (Large ribosomal subunit protein eL15)%$#RPL15 EC45 TCBAP0781%$#TRUE%$#FALSE
P18621%$#60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)%$#RPL17%$#TRUE%$#FALSE
Q07020%$#60S ribosomal protein L18 (Large ribosomal subunit protein eL18)%$#RPL18%$#TRUE%$#FALSE
Q02543%$#60S ribosomal protein L18a (Large ribosomal subunit protein eL20)%$#RPL18A%$#TRUE%$#FALSE
P84098%$#60S ribosomal protein L19 (Large ribosomal subunit protein eL19)%$#RPL19%$#TRUE%$#FALSE
P46778%$#60S ribosomal protein L21 (Large ribosomal subunit protein eL21)%$#RPL21%$#TRUE%$#FALSE
P35268%$#60S ribosomal protein L22 (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15) (Large ribosomal subunit protein eL22)%$#RPL22%$#TRUE%$#FALSE
P62829%$#60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14)%$#RPL23%$#TRUE%$#FALSE
P62750%$#60S ribosomal protein L23a (Large ribosomal subunit protein uL23)%$#RPL23A%$#TRUE%$#TRUE
P83731%$#60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)%$#RPL24%$#TRUE%$#FALSE
P61254%$#60S ribosomal protein L26 (Large ribosomal subunit protein uL24)%$#RPL26%$#TRUE%$#FALSE
P61353%$#60S ribosomal protein L27 (Large ribosomal subunit protein eL27)%$#RPL27%$#TRUE%$#FALSE
P46776%$#60S ribosomal protein L27a (Large ribosomal subunit protein uL15)%$#RPL27A%$#TRUE%$#FALSE
P46779%$#60S ribosomal protein L28 (Large ribosomal subunit protein eL28)%$#RPL28%$#TRUE%$#FALSE
P47914%$#60S ribosomal protein L29 (Cell surface heparin-binding protein HIP) (Large ribosomal subunit protein eL29)%$#RPL29%$#TRUE%$#TRUE
P39023%$#60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3)%$#RPL3 OK/SW-cl.32%$#TRUE%$#FALSE
P62888%$#60S ribosomal protein L30 (Large ribosomal subunit protein eL30)%$#RPL30%$#TRUE%$#FALSE
P62899%$#60S ribosomal protein L31 (Large ribosomal subunit protein eL31)%$#RPL31%$#TRUE%$#FALSE
P62910%$#60S ribosomal protein L32 (Large ribosomal subunit protein eL32)%$#RPL32 PP9932%$#TRUE%$#FALSE
P49207%$#60S ribosomal protein L34 (Large ribosomal subunit protein eL34)%$#RPL34%$#TRUE%$#FALSE
P42766%$#60S ribosomal protein L35 (Large ribosomal subunit protein uL29)%$#RPL35%$#TRUE%$#FALSE
Q9Y3U8%$#60S ribosomal protein L36 (Large ribosomal subunit protein eL36)%$#RPL36%$#TRUE%$#FALSE
P83881%$#60S ribosomal protein L36a (60S ribosomal protein L44) (Cell growth-inhibiting gene 15 protein) (Cell migration-inducing gene 6 protein) (Large ribosomal subunit protein eL42)%$#RPL36A RPL44 GIG15 MIG6%$#TRUE%$#FALSE
P61513%$#60S ribosomal protein L37a (Large ribosomal subunit protein eL43)%$#RPL37A%$#TRUE%$#FALSE
P36578%$#60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)%$#RPL4 RPL1%$#TRUE%$#FALSE
P46777%$#60S ribosomal protein L5 (Large ribosomal subunit protein uL18)%$#RPL5 MSTP030%$#TRUE%$#FALSE
Q02878%$#60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)%$#RPL6 TXREB1%$#TRUE%$#FALSE
P18124%$#60S ribosomal protein L7 (Large ribosomal subunit protein uL30)%$#RPL7%$#TRUE%$#TRUE
P62424%$#60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)%$#RPL7A SURF-3 SURF3%$#TRUE%$#FALSE
P62917%$#60S ribosomal protein L8 (Large ribosomal subunit protein uL2)%$#RPL8%$#TRUE%$#FALSE
P32969%$#60S ribosomal protein L9 (Large ribosomal subunit protein uL6)%$#RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9%$#TRUE%$#FALSE
P05388%$#60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)%$#RPLP0%$#TRUE%$#FALSE
P05387%$#60S acidic ribosomal protein P2 (Large ribosomal subunit protein P2) (Renal carcinoma antigen NY-REN-44)%$#RPLP2 D11S2243E RPP2%$#TRUE%$#TRUE
P04843%$#Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)%$#RPN1%$#TRUE%$#FALSE
P04844%$#Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2)%$#RPN2%$#TRUE%$#FALSE
P46783%$#40S ribosomal protein S10 (Small ribosomal subunit protein eS10)%$#RPS10%$#TRUE%$#FALSE
P62280%$#40S ribosomal protein S11 (Small ribosomal subunit protein uS17)%$#RPS11%$#TRUE%$#FALSE
P25398%$#40S ribosomal protein S12 (Small ribosomal subunit protein eS12)%$#RPS12%$#TRUE%$#FALSE
P62277%$#40S ribosomal protein S13 (Small ribosomal subunit protein uS15)%$#RPS13%$#TRUE%$#FALSE
P62263%$#40S ribosomal protein S14 (Small ribosomal subunit protein uS11)%$#RPS14 PRO2640%$#TRUE%$#FALSE
P62841%$#40S ribosomal protein S15 (RIG protein) (Small ribosomal subunit protein uS19)%$#RPS15 RIG%$#TRUE%$#FALSE
P62244%$#40S ribosomal protein S15a (Small ribosomal subunit protein uS8)%$#RPS15A OK/SW-cl.82%$#TRUE%$#FALSE
P62249%$#40S ribosomal protein S16 (Small ribosomal subunit protein uS9)%$#RPS16%$#TRUE%$#FALSE
P08708%$#40S ribosomal protein S17 (Small ribosomal subunit protein eS17)%$#RPS17 RPS17L%$#TRUE%$#TRUE
P62269%$#40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)%$#RPS18 D6S218E%$#TRUE%$#FALSE
P39019%$#40S ribosomal protein S19 (Small ribosomal subunit protein eS19)%$#RPS19%$#TRUE%$#FALSE
P15880%$#40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)%$#RPS2 RPS4%$#TRUE%$#FALSE
P60866%$#40S ribosomal protein S20 (Small ribosomal subunit protein uS10)%$#RPS20%$#TRUE%$#TRUE
P63220%$#40S ribosomal protein S21 (Small ribosomal subunit protein eS21)%$#RPS21%$#TRUE%$#FALSE
P62266%$#40S ribosomal protein S23 (Small ribosomal subunit protein uS12)%$#RPS23%$#TRUE%$#FALSE
P62847%$#40S ribosomal protein S24 (Small ribosomal subunit protein eS24)%$#RPS24%$#TRUE%$#FALSE
P62851%$#40S ribosomal protein S25 (Small ribosomal subunit protein eS25)%$#RPS25%$#TRUE%$#FALSE
P62854%$#40S ribosomal protein S26 (Small ribosomal subunit protein eS26)%$#RPS26%$#TRUE%$#FALSE
P42677%$#40S ribosomal protein S27 (Metallopan-stimulin 1) (MPS-1) (Small ribosomal subunit protein eS27)%$#RPS27 MPS1%$#FALSE%$#TRUE
P62979%$#Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a (Small ribosomal subunit protein eS31)]%$#RPS27A UBA80 UBCEP1%$#TRUE%$#FALSE
Q71UM5%$#40S ribosomal protein S27-like (Small ribosomal subunit protein eS27-like)%$#RPS27L%$#TRUE%$#FALSE
P62857%$#40S ribosomal protein S28 (Small ribosomal subunit protein eS28)%$#RPS28%$#TRUE%$#FALSE
P23396%$#40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)%$#RPS3 OK/SW-cl.26%$#TRUE%$#FALSE
P61247%$#40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)%$#RPS3A FTE1 MFTL%$#TRUE%$#TRUE
P62701%$#40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)%$#RPS4X CCG2 RPS4 SCAR%$#TRUE%$#FALSE
P46782%$#40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]%$#RPS5%$#TRUE%$#FALSE
P62753%$#40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)%$#RPS6 OK/SW-cl.2%$#TRUE%$#FALSE
P62081%$#40S ribosomal protein S7 (Small ribosomal subunit protein eS7)%$#RPS7%$#TRUE%$#FALSE
P62241%$#40S ribosomal protein S8 (Small ribosomal subunit protein eS8)%$#RPS8 OK/SW-cl.83%$#TRUE%$#FALSE
P46781%$#40S ribosomal protein S9 (Small ribosomal subunit protein uS4)%$#RPS9%$#TRUE%$#FALSE
P08865%$#40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)%$#RPSA LAMBR LAMR1%$#TRUE%$#FALSE
P10301%$#Ras-related protein R-Ras (p23)%$#RRAS%$#TRUE%$#FALSE
P62070%$#Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene)%$#RRAS2 TC21%$#TRUE%$#FALSE
Q9P2E9%$#Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein)%$#RRBP1 KIAA1398%$#TRUE%$#FALSE
Q9Y3I0%$#tRNA-splicing ligase RtcB homolog (EC 6.5.1.3)%$#RTCB C22orf28 HSPC117%$#TRUE%$#FALSE
O95197%$#Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII)%$#RTN3 ASYIP NSPL2%$#TRUE%$#FALSE
Q9NQC3%$#Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)%$#RTN4 KIAA0886 NOGO My043 SP1507%$#TRUE%$#FALSE
P23297%$#Protein S100-A1 (S-100 protein alpha chain) (S-100 protein subunit alpha) (S100 calcium-binding protein A1)%$#S100A1 S100A%$#TRUE%$#FALSE
P31949%$#Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11) [Cleaved into: Protein S100-A11, N-terminally processed]%$#S100A11 MLN70 S100C%$#TRUE%$#FALSE
P80511%$#Protein S100-A12 (CGRP) (Calcium-binding protein in amniotic fluid 1) (CAAF1) (Calgranulin-C) (CAGC) (Extracellular newly identified RAGE-binding protein) (EN-RAGE) (Migration inhibitory factor-related protein 6) (MRP-6) (p6) (Neutrophil S100 protein) (S100 calcium-binding protein A12) [Cleaved into: Calcitermin]%$#S100A12%$#TRUE%$#FALSE
Q99584%$#Protein S100-A13 (S100 calcium-binding protein A13)%$#S100A13%$#TRUE%$#FALSE
Q9HCY8%$#Protein S100-A14 (S100 calcium-binding protein A14) (S114)%$#S100A14 S100A15%$#TRUE%$#FALSE
Q96FQ6%$#Protein S100-A16 (Aging-associated gene 13 protein) (Protein S100-F) (S100 calcium-binding protein A16)%$#S100A16 S100F AAG13%$#TRUE%$#FALSE
P26447%$#Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4)%$#S100A4 CAPL MTS1%$#TRUE%$#FALSE
P06703%$#Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6)%$#S100A6 CACY%$#TRUE%$#FALSE
P05109%$#Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A)%$#S100A8 CAGA CFAG MRP8%$#TRUE%$#FALSE
P06702%$#Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9)%$#S100A9 CAGB CFAG MRP14%$#TRUE%$#FALSE
P04271%$#Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B)%$#S100B%$#TRUE%$#FALSE
P25815%$#Protein S100-P (Migration-inducing gene 9 protein) (MIG9) (Protein S100-E) (S100 calcium-binding protein P)%$#S100P S100E%$#TRUE%$#FALSE
P0DJI8%$#Serum amyloid A-1 protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)]%$#SAA1%$#TRUE%$#TRUE
P0DJI9%$#Serum amyloid A-2 protein (SAA2)%$#SAA2%$#TRUE%$#TRUE
P35542%$#Serum amyloid A-4 protein (Constitutively expressed serum amyloid A protein) (C-SAA)%$#SAA4 CSAA%$#TRUE%$#FALSE
Q9Y3Z3%$#Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1)%$#SAMHD1 MOP5%$#TRUE%$#FALSE
Q9NR31%$#GTP-binding protein SAR1a (COPII-associated small GTPase)%$#SAR1A SAR1 SARA SARA1%$#TRUE%$#FALSE
Q9Y6B6%$#GTP-binding protein SAR1b (GTP-binding protein B) (GTBPB)%$#SAR1B SARA2 SARB%$#TRUE%$#FALSE
P49591%$#Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)%$#SARS SERS%$#TRUE%$#FALSE
Q6UWP8%$#Suprabasin%$#SBSN UNQ698/PRO1343%$#TRUE%$#FALSE
Q8WTV0%$#Scavenger receptor class B member 1 (SRB1) (CD36 and LIMPII analogous 1) (CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)%$#SCARB1 CD36L1 CLA1%$#TRUE%$#FALSE
Q96QR1%$#Secretoglobin family 3A member 1 (Cytokine HIN-1) (High in normal 1) (Pneumo secretory protein 2) (PnSP-2) (Uteroglobin-related protein 2)%$#SCGB3A1 HIN1 PNSP2 UGRP2 UNQ629/PRO1245%$#TRUE%$#FALSE
P22307%$#Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)%$#SCP2%$#TRUE%$#FALSE
Q9HB40%$#Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)%$#SCPEP1 RISC SCP1 MSTP034 UNQ265/PRO302%$#TRUE%$#FALSE
P34741%$#Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362)%$#SDC2 HSPG1%$#FALSE%$#TRUE
P31431%$#Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein)%$#SDC4%$#TRUE%$#TRUE
O00560%$#Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)%$#SDCBP MDA9 SYCL%$#TRUE%$#TRUE
Q9BRK5%$#45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4)%$#SDF4 CAB45 PSEC0034%$#TRUE%$#FALSE
Q92503%$#SEC14-like protein 1%$#SEC14L1 SEC14L%$#TRUE%$#FALSE
O75396%$#Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1)%$#SEC22B SEC22L1%$#TRUE%$#FALSE
O94979%$#Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein)%$#SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334%$#TRUE%$#FALSE
P61619%$#Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)%$#SEC61A1 SEC61A%$#TRUE%$#FALSE
P60468%$#Protein transport protein Sec61 subunit beta%$#SEC61B%$#TRUE%$#TRUE
Q13228%$#Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1)%$#SELENBP1 SBP%$#TRUE%$#FALSE
O60613%$#Selenoprotein F (15 kDa selenoprotein)%$#SELENOF SEP15%$#TRUE%$#FALSE
P49908%$#Selenoprotein P (SeP)%$#SELENOP SELP SEPP1%$#TRUE%$#FALSE
Q16181%$#Septin-7 (CDC10 protein homolog)%$#SEPTIN7 CDC10 SEPT7%$#TRUE%$#FALSE
Q8NC51%$#Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)%$#SERBP1 PAIRBP1 CGI-55%$#TRUE%$#FALSE
Q96SA4%$#Serine incorporator 2 (Tumor differentially expressed protein 2-like)%$#SERINC2 TDE2L FKSG84 UNQ263/PRO300%$#TRUE%$#FALSE
P01009%$#Alpha-1-antitrypsin (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Cleaved into: Short peptide from AAT (SPAAT)]%$#SERPINA1 AAT PI PRO0684 PRO2209%$#TRUE%$#FALSE
P01011%$#Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]%$#SERPINA3 AACT GIG24 GIG25%$#TRUE%$#FALSE
P29622%$#Kallistatin (Kallikrein inhibitor) (Peptidase inhibitor 4) (PI-4) (Serpin A4)%$#SERPINA4 KST PI4%$#TRUE%$#FALSE
P05154%$#Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5)%$#SERPINA5 PCI PLANH3 PROCI%$#TRUE%$#FALSE
P08185%$#Corticosteroid-binding globulin (CBG) (Serpin A6) (Transcortin)%$#SERPINA6 CBG%$#TRUE%$#FALSE
P05543%$#Thyroxine-binding globulin (Serpin A7) (T4-binding globulin)%$#SERPINA7 TBG%$#TRUE%$#FALSE
P30740%$#Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1)%$#SERPINB1 ELANH2 MNEI PI2%$#TRUE%$#FALSE
P29508%$#Serpin B3 (Protein T4-A) (Squamous cell carcinoma antigen 1) (SCCA-1)%$#SERPINB3 SCCA SCCA1%$#TRUE%$#FALSE
P48594%$#Serpin B4 (Leupin) (Peptidase inhibitor 11) (PI-11) (Squamous cell carcinoma antigen 2) (SCCA-2)%$#SERPINB4 PI11 SCCA2%$#TRUE%$#FALSE
P35237%$#Serpin B6 (Cytoplasmic antiproteinase) (CAP) (Peptidase inhibitor 6) (PI-6) (Placental thrombin inhibitor)%$#SERPINB6 PI6 PTI%$#TRUE%$#FALSE
P01008%$#Antithrombin-III (ATIII) (Serpin C1)%$#SERPINC1 AT3 PRO0309%$#TRUE%$#FALSE
P05546%$#Heparin cofactor 2 (Heparin cofactor II) (HC-II) (Protease inhibitor leuserpin-2) (HLS2) (Serpin D1)%$#SERPIND1 HCF2%$#TRUE%$#FALSE
P07093%$#Glia-derived nexin (GDN) (Peptidase inhibitor 7) (PI-7) (Protease nexin 1) (PN-1) (Protease nexin I) (Serpin E2)%$#SERPINE2 PI7 PN1%$#TRUE%$#FALSE
P36955%$#Pigment epithelium-derived factor (PEDF) (Cell proliferation-inducing gene 35 protein) (EPC-1) (Serpin F1)%$#SERPINF1 PEDF PIG35%$#TRUE%$#FALSE
P08697%$#Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2)%$#SERPINF2 AAP PLI%$#TRUE%$#TRUE
P05155%$#Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)%$#SERPING1 C1IN C1NH%$#TRUE%$#FALSE
Q99574%$#Neuroserpin (Peptidase inhibitor 12) (PI-12) (Serpin I1)%$#SERPINI1 PI12%$#TRUE%$#FALSE
O15047%$#Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.43) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)%$#SETD1A KIAA0339 KMT2F SET1 SET1A%$#FALSE%$#TRUE
P31947%$#14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin)%$#SFN HME1%$#TRUE%$#FALSE
Q8N474%$#Secreted frizzled-related protein 1 (FRP-1) (sFRP-1) (Secreted apoptosis-related protein 2) (SARP-2)%$#SFRP1 FRP FRP1 SARP2%$#TRUE%$#TRUE
O75368%$#SH3 domain-binding glutamic acid-rich-like protein%$#SH3BGRL%$#TRUE%$#FALSE
Q9H299%$#SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1) (SH3BP-1)%$#SH3BGRL3 P1725%$#TRUE%$#FALSE
P04278%$#Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin)%$#SHBG%$#TRUE%$#FALSE
P34896%$#Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)%$#SHMT1%$#TRUE%$#FALSE
Q9HAT2%$#Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase)%$#SIAE YSG2%$#TRUE%$#FALSE
Q9H173%$#Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP)%$#SIL1 UNQ545/PRO836%$#TRUE%$#TRUE
P78324%$#Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a)%$#SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP%$#TRUE%$#TRUE
P63208%$#S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1)%$#SKP1 EMC19 OCP2 SKP1A TCEB1L%$#TRUE%$#FALSE
Q13183%$#Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)%$#SLC13A2 NADC1 SDCT1%$#TRUE%$#FALSE
Q16348%$#Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)%$#SLC15A2 PEPT2%$#TRUE%$#TRUE
P53985%$#Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1)%$#SLC16A1 MCT1%$#TRUE%$#FALSE
Q15758%$#Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5)%$#SLC1A5 ASCT2 M7V1 RDR RDRC%$#TRUE%$#TRUE
P05141%$#ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]%$#SLC25A5 ANT2%$#TRUE%$#FALSE
Q9HAS3%$#Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (hCNT3)%$#SLC28A3 CNT3%$#TRUE%$#FALSE
O95436%$#Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2)%$#SLC34A2%$#TRUE%$#TRUE
P08195%$#4F2 cell-surface antigen heavy chain (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)%$#SLC3A2 MDU1%$#TRUE%$#FALSE
Q8IWA5%$#Choline transporter-like protein 2 (Solute carrier family 44 member 2)%$#SLC44A2 CTL2 PSEC0210%$#TRUE%$#FALSE
P13866%$#Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1)%$#SLC5A1 NAGT SGLT1%$#TRUE%$#FALSE
Q9UN76%$#Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14)%$#SLC6A14%$#TRUE%$#FALSE
P19634%$#Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)%$#SLC9A1 APNH1 NHE1%$#FALSE%$#TRUE
O14745%$#Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)%$#SLC9A3R1 NHERF NHERF1%$#TRUE%$#FALSE
Q15599%$#Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1) (TKA-1)%$#SLC9A3R2 NHERF2%$#TRUE%$#FALSE
Q9H2G2%$#STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)%$#SLK KIAA0204 STK2%$#TRUE%$#FALSE
P03973%$#Antileukoproteinase (ALP) (BLPI) (HUSI-1) (Mucus proteinase inhibitor) (MPI) (Protease inhibitor WAP4) (Secretory leukocyte protease inhibitor) (Seminal proteinase inhibitor) (WAP four-disulfide core domain protein 4)%$#SLPI WAP4 WFDC4%$#TRUE%$#FALSE
K7EJ46%$#Small integral membrane protein 22 (Cancer-associated small integral membrane open reading frame 1)%$#SMIM22 CASIMO1%$#FALSE%$#TRUE
Q92485%$#Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)%$#SMPDL3B ASML3B ASMLPD%$#TRUE%$#FALSE
O00161%$#Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23)%$#SNAP23%$#TRUE%$#TRUE
Q7KZF4%$#Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)%$#SND1 TDRD11%$#TRUE%$#FALSE
P62318%$#Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)%$#SNRPD3%$#TRUE%$#FALSE
Q13596%$#Sorting nexin-1%$#SNX1%$#TRUE%$#FALSE
P00441%$#Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1)%$#SOD1%$#TRUE%$#FALSE
P04179%$#Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)%$#SOD2%$#TRUE%$#FALSE
P08294%$#Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1)%$#SOD3%$#TRUE%$#FALSE
Q92673%$#Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA)%$#SORL1 C11orf32%$#FALSE%$#TRUE
Q99523%$#Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3)%$#SORT1%$#FALSE%$#TRUE
Q6X4U4%$#Sclerostin domain-containing protein 1 (Ectodermal BMP inhibitor) (Ectodin) (Uterine sensitization-associated gene 1 protein) (USAG-1)%$#SOSTDC1 USAG1 CDA019%$#TRUE%$#TRUE
Q14515%$#SPARC-like protein 1 (High endothelial venule protein) (Hevin) (MAST 9)%$#SPARCL1%$#TRUE%$#FALSE
Q9Y6A9%$#Signal peptidase complex subunit 1 (EC 3.4.-.-) (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit)%$#SPCS1 SPC12 HSPC033%$#TRUE%$#FALSE
Q15005%$#Signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit)%$#SPCS2 KIAA0102 SPC25%$#TRUE%$#FALSE
P61009%$#Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit)%$#SPCS3 SPC22 UNQ1841/PRO3567%$#TRUE%$#FALSE
O43278%$#Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1) (HAI-1)%$#SPINT1 HAI1 UNQ223/PRO256%$#TRUE%$#FALSE
P10451%$#Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin)%$#SPP1 BNSP OPN PSEC0156%$#TRUE%$#TRUE
Q13813%$#Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)%$#SPTAN1 NEAS SPTA2%$#TRUE%$#FALSE
Q13501%$#Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)%$#SQSTM1 ORCA OSIL%$#TRUE%$#FALSE
Q9UHB9%$#Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)%$#SRP68%$#TRUE%$#FALSE
P08240%$#Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)%$#SRPRA SRPR%$#TRUE%$#FALSE
Q9Y5M8%$#Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1)%$#SRPRB PSEC0230%$#TRUE%$#FALSE
Q8IYB3%$#Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein)%$#SRRM1 SRM160%$#FALSE%$#TRUE
Q07955%$#Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)%$#SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3%$#TRUE%$#FALSE
P43307%$#Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)%$#SSR1 TRAPA PSEC0262%$#TRUE%$#FALSE
Q9UNL2%$#Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)%$#SSR3 TRAPG%$#FALSE%$#TRUE
P51571%$#Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta)%$#SSR4 TRAPD%$#TRUE%$#FALSE
P50502%$#Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein)%$#ST13 AAG2 FAM10A1 HIP SNC6%$#TRUE%$#FALSE
Q9Y5Y6%$#Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)%$#ST14 PRSS14 SNC19 TADG15%$#TRUE%$#FALSE
P15907%$#Beta-galactoside alpha-2,6-sialyltransferase 1 (Alpha 2,6-ST 1) (EC 2.4.99.1) (B-cell antigen CD75) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I) (ST6GalI) (Sialyltransferase 1)%$#ST6GAL1 SIAT1%$#TRUE%$#FALSE
P40763%$#Signal transducer and activator of transcription 3 (Acute-phase response factor)%$#STAT3 APRF%$#TRUE%$#FALSE
P42229%$#Signal transducer and activator of transcription 5A%$#STAT5A STAT5%$#TRUE%$#FALSE
O95793%$#Double-stranded RNA-binding protein Staufen homolog 1%$#STAU1 STAU%$#TRUE%$#TRUE
P52823%$#Stanniocalcin-1 (STC-1)%$#STC1 STC%$#TRUE%$#TRUE
Q687X5%$#Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)%$#STEAP4 STAMP2 TNFAIP9%$#TRUE%$#FALSE
P31948%$#Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)%$#STIP1%$#TRUE%$#FALSE
Q9Y6E0%$#Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]%$#STK24 MST3 STK3%$#TRUE%$#FALSE
P16949%$#Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17)%$#STMN1 C1orf215 LAP18 OP18%$#FALSE%$#TRUE
P27105%$#Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin)%$#STOM BND7 EPB72%$#TRUE%$#FALSE
P46977%$#Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1) (Transmembrane protein TMC)%$#STT3A ITM1 TMC%$#TRUE%$#FALSE
Q8TCJ2%$#Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog)%$#STT3B SIMP%$#TRUE%$#FALSE
Q13277%$#Syntaxin-3%$#STX3 STX3A%$#TRUE%$#FALSE
O15400%$#Syntaxin-7%$#STX7%$#TRUE%$#FALSE
P61764%$#Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A) (p67)%$#STXBP1 UNC18A%$#TRUE%$#FALSE
Q15833%$#Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Unc18-2) (Protein unc-18 homolog B) (Unc-18B)%$#STXBP2 UNC18B%$#TRUE%$#FALSE
P53999%$#Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14)%$#SUB1 PC4 RPO2TC1%$#TRUE%$#FALSE
Q9Y2Z0%$#Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog)%$#SUGT1%$#TRUE%$#FALSE
Q8IWU5%$#Extracellular sulfatase Sulf-2 (hSulf-2) (EC 3.1.6.-)%$#SULF2 KIAA1247 UNQ559/PRO1120%$#TRUE%$#FALSE
P50225%$#Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST)%$#SULT1A1 STP STP1 OK/SW-cl.88%$#TRUE%$#FALSE
Q8NBJ7%$#Inactive C-alpha-formylglycine-generating enzyme 2 (Paralog of formylglycine-generating enzyme) (pFGE) (Sulfatase-modifying factor 2)%$#SUMF2 PSEC0171 UNQ1968/PRO4500%$#TRUE%$#FALSE
P55854%$#Small ubiquitin-related modifier 3 (SUMO-3) (SMT3 homolog 1) (SUMO-2) (Ubiquitin-like protein SMT3A) (Smt3A)%$#SUMO3 SMT3A SMT3H1%$#TRUE%$#FALSE
O15260%$#Surfeit locus protein 4%$#SURF4 SURF-4%$#TRUE%$#FALSE
Q96A49%$#Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA)%$#SYAP1 PRO3113%$#TRUE%$#FALSE
O43581%$#Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)%$#SYT7 PCANAP7%$#FALSE%$#TRUE
P37802%$#Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)%$#TAGLN2 KIAA0120 CDABP0035%$#TRUE%$#TRUE
P37837%$#Transaldolase (EC 2.2.1.2)%$#TALDO1 TAL TALDO TALDOR%$#TRUE%$#FALSE
P26639%$#Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)%$#TARS%$#TRUE%$#FALSE
Q8N9U0%$#Tandem C2 domains nuclear protein (Membrane targeting tandem C2 domain-containing protein 1) (Tandem C2 protein in nucleus) (Tac2-N)%$#TC2N C14orf47 MTAC2D1%$#TRUE%$#TRUE
P20061%$#Transcobalamin-1 (TC-1) (Haptocorrin) (HC) (Protein R) (Transcobalamin I) (TC I) (TCI)%$#TCN1 TC1%$#TRUE%$#FALSE
P17987%$#T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)%$#TCP1 CCT1 CCTA%$#TRUE%$#FALSE
Q9NZ01%$#Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)%$#TECR GPSN2 SC2%$#TRUE%$#FALSE
P02787%$#Serotransferrin (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin)%$#TF PRO1400%$#TRUE%$#FALSE
Q92734%$#Protein TFG (TRK-fused gene protein)%$#TFG%$#TRUE%$#FALSE
O43493%$#Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51)%$#TGOLN2 TGN46 TGN51%$#TRUE%$#FALSE
P07996%$#Thrombospondin-1 (Glycoprotein G)%$#THBS1 TSP TSP1%$#TRUE%$#FALSE
P49746%$#Thrombospondin-3%$#THBS3 TSP3%$#TRUE%$#FALSE
P35443%$#Thrombospondin-4%$#THBS4 TSP4%$#TRUE%$#FALSE
P01033%$#Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1)%$#TIMP1 CLGI TIMP%$#TRUE%$#FALSE
Q99727%$#Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)%$#TIMP4%$#TRUE%$#FALSE
Q9GZM7%$#Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP)%$#TINAGL1 GIS5 LCN7 OLRG2 TINAGL PP6614 PSEC0088 UNQ204/PRO230%$#TRUE%$#FALSE
P29401%$#Transketolase (TK) (EC 2.2.1.1)%$#TKT%$#TRUE%$#FALSE
Q9Y490%$#Talin-1%$#TLN1 KIAA1027 TLN%$#TRUE%$#FALSE
O60603%$#Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282)%$#TLR2 TIL4%$#TRUE%$#TRUE
Q99805%$#Transmembrane 9 superfamily member 2 (p76)%$#TM9SF2%$#TRUE%$#FALSE
Q969X1%$#Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1)%$#TMBIM1 LFG3 RECS1 PP1201 PSEC0158%$#TRUE%$#FALSE
Q7Z404%$#Transmembrane channel-like protein 4%$#TMC4%$#TRUE%$#FALSE
Q6UXY8%$#Transmembrane channel-like protein 5%$#TMC5 UNQ8238/PRO33604%$#TRUE%$#FALSE
P49755%$#Transmembrane emp24 domain-containing protein 10 (21 kDa transmembrane-trafficking protein) (S31III125) (S31I125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta)%$#TMED10 TMP21%$#TRUE%$#FALSE
Q15363%$#Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1)%$#TMED2 RNP24%$#TRUE%$#FALSE
Q9Y3B3%$#Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)%$#TMED7 CGI-109%$#TRUE%$#FALSE
Q9BVK6%$#Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25)%$#TMED9 GP25L2%$#TRUE%$#FALSE
Q9BXJ8%$#Transmembrane protein 120A (Transmembrane protein induced by tumor necrosis factor alpha)%$#TMEM120A TMPIT%$#TRUE%$#FALSE
Q8WUH6%$#Transmembrane protein 263%$#TMEM263 C12orf23%$#TRUE%$#TRUE
P63313%$#Thymosin beta-10%$#TMSB10 PTMB10 THYB10%$#FALSE%$#TRUE
P62328%$#Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hematopoietic system regulatory peptide (Seraspenide)]%$#TMSB4X TB4X THYB4 TMSB4%$#TRUE%$#TRUE
Q9H3N1%$#Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein)%$#TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268%$#TRUE%$#TRUE
P24821%$#Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)%$#TNC HXB%$#TRUE%$#TRUE
O00300%$#Tumor necrosis factor receptor superfamily member 11B (Osteoclastogenesis inhibitory factor) (Osteoprotegerin)%$#TNFRSF11B OCIF OPG%$#TRUE%$#FALSE
P50591%$#Tumor necrosis factor ligand superfamily member 10 (Apo-2 ligand) (Apo-2L) (TNF-related apoptosis-inducing ligand) (Protein TRAIL) (CD antigen CD253)%$#TNFSF10 APO2L TRAIL%$#TRUE%$#FALSE
O75888%$#Tumor necrosis factor ligand superfamily member 13 (A proliferation-inducing ligand) (APRIL) (TNF- and APOL-related leukocyte expressed ligand 2) (TALL-2) (TNF-related death ligand 1) (TRDL-1) (CD antigen CD256)%$#TNFSF13 APRIL TALL2 ZTNF2 UNQ383/PRO715%$#TRUE%$#TRUE
Q9H0E2%$#Toll-interacting protein%$#TOLLIP%$#TRUE%$#FALSE
Q9NS69%$#Mitochondrial import receptor subunit TOM22 homolog (hTom22) (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog)%$#TOMM22 TOM22%$#FALSE%$#TRUE
P55327%$#Tumor protein D52 (Protein N8)%$#TPD52%$#TRUE%$#TRUE
Q16890%$#Tumor protein D53 (hD53) (Tumor protein D52-like 1)%$#TPD52L1%$#TRUE%$#FALSE
O43399%$#Tumor protein D54 (hD54) (Tumor protein D52-like 2)%$#TPD52L2%$#TRUE%$#FALSE
P60174%$#Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase)%$#TPI1 TPI%$#TRUE%$#FALSE
P09493%$#Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)%$#TPM1 C15orf13 TMSA%$#TRUE%$#FALSE
P06753%$#Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5)%$#TPM3%$#TRUE%$#FALSE
P67936%$#Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4)%$#TPM4%$#TRUE%$#FALSE
O14773%$#Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I)%$#TPP1 CLN2 GIG1 UNQ267/PRO304%$#TRUE%$#FALSE
P13693%$#Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23)%$#TPT1%$#TRUE%$#FALSE
Q99816%$#Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)%$#TSG101%$#TRUE%$#FALSE
Q15631%$#Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)%$#TSN%$#TRUE%$#FALSE
O43657%$#Tetraspanin-6 (Tspan-6) (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6)%$#TSPAN6 TM4SF6 UNQ767/PRO1560%$#TRUE%$#FALSE
O75954%$#Tetraspanin-9 (Tspan-9) (Tetraspan NET-5)%$#TSPAN9 NET5%$#TRUE%$#TRUE
Q13630%$#GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)%$#TSTA3 SDR4E1%$#TRUE%$#FALSE
P02766%$#Transthyretin (ATTR) (Prealbumin) (TBPA)%$#TTR PALB%$#TRUE%$#FALSE
P68363%$#Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]%$#TUBA1B%$#TRUE%$#TRUE
P68366%$#Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)%$#TUBA4A TUBA1%$#TRUE%$#FALSE
P07437%$#Tubulin beta chain (Tubulin beta-5 chain)%$#TUBB TUBB5 OK/SW-cl.56%$#TRUE%$#FALSE
P68371%$#Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)%$#TUBB4B TUBB2C%$#TRUE%$#FALSE
Q9BUF5%$#Tubulin beta-6 chain (Tubulin beta class V)%$#TUBB6%$#TRUE%$#FALSE
Q12792%$#Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9)%$#TWF1 PTK9%$#TRUE%$#FALSE
Q6IBS0%$#Twinfilin-2 (A6-related protein) (hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein)%$#TWF2 PTK9L MSTP011%$#TRUE%$#FALSE
P10599%$#Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP)%$#TXN TRDX TRX TRX1%$#TRUE%$#FALSE
Q9P2K2%$#Thioredoxin domain-containing protein 16%$#TXNDC16 ERP90 KIAA1344%$#TRUE%$#FALSE
Q9BRA2%$#Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5)%$#TXNDC17 TXNL5%$#TRUE%$#FALSE
Q8NBS9%$#Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)%$#TXNDC5 TLP46 UNQ364/PRO700%$#TRUE%$#FALSE
Q16881%$#Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1)%$#TXNRD1 GRIM12 KDRF%$#TRUE%$#FALSE
P19971%$#Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)%$#TYMP ECGF1%$#TRUE%$#FALSE
P22314%$#Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)%$#UBA1 A1S9T UBE1%$#TRUE%$#FALSE
P61077%$#Ubiquitin-conjugating enzyme E2 D3 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D3) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-conjugating enzyme E2(17)KB 3) (Ubiquitin-conjugating enzyme E2-17 kDa 3) (Ubiquitin-protein ligase D3)%$#UBE2D3 UBC5C UBCH5C%$#TRUE%$#FALSE
P60604%$#Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)%$#UBE2G2%$#TRUE%$#FALSE
P68036%$#Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3)%$#UBE2L3 UBCE7 UBCH7%$#TRUE%$#FALSE
P61088%$#Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N)%$#UBE2N BLU%$#TRUE%$#FALSE
Q13404%$#Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)%$#UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19%$#TRUE%$#FALSE
O95164%$#Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (HsMUB) (MUB) (Protein HCG-1)%$#UBL3 PNSC1%$#TRUE%$#FALSE
Q5T4S7%$#E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)%$#UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1%$#FALSE%$#TRUE
P15374%$#Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3)%$#UCHL3%$#TRUE%$#FALSE
O94874%$#E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)%$#UFL1 KIAA0776 MAXER NLBP RCAD%$#TRUE%$#FALSE
P61960%$#Ubiquitin-fold modifier 1%$#UFM1 C13orf20 BM-002%$#TRUE%$#FALSE
Q9NYU2%$#UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (hUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)%$#UGGT1 GT UGCGL1 UGGT UGT1 UGTR%$#TRUE%$#FALSE
Q16851%$#UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)%$#UGP2 UGP1%$#TRUE%$#FALSE
P31930%$#Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)%$#UQCRC1%$#TRUE%$#FALSE
P22695%$#Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)%$#UQCRC2%$#TRUE%$#FALSE
P54578%$#Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)%$#USP14 TGT%$#TRUE%$#FALSE
Q9P0L0%$#Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33)%$#VAPA VAP33%$#TRUE%$#FALSE
P26640%$#Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)%$#VARS G7A VARS2%$#TRUE%$#FALSE
P50552%$#Vasodilator-stimulated phosphoprotein (VASP)%$#VASP%$#TRUE%$#FALSE
Q99536%$#Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-)%$#VAT1%$#TRUE%$#TRUE
P19320%$#Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106)%$#VCAM1%$#TRUE%$#FALSE
P18206%$#Vinculin (Metavinculin) (MV)%$#VCL%$#TRUE%$#FALSE
P55072%$#Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)%$#VCP%$#TRUE%$#FALSE
P21796%$#Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM)%$#VDAC1 VDAC%$#TRUE%$#FALSE
P08670%$#Vimentin%$#VIM%$#TRUE%$#TRUE
Q96QK1%$#Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35)%$#VPS35 MEM3 TCCCTA00141%$#TRUE%$#FALSE
O75351%$#Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)%$#VPS4B SKD1 VPS42 MIG1%$#TRUE%$#FALSE
Q7Z7D3%$#V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x)%$#VTCN1 B7H4 UNQ659/PRO1291%$#FALSE%$#TRUE
P04004%$#Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]%$#VTN%$#TRUE%$#FALSE
Q6PCB0%$#von Willebrand factor A domain-containing protein 1%$#VWA1%$#TRUE%$#TRUE
P23381%$#Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]%$#WARS IFI53 WRS%$#TRUE%$#FALSE
Q969T9%$#WW domain-binding protein 2 (WBP-2)%$#WBP2%$#TRUE%$#TRUE
O75083%$#WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1)%$#WDR1%$#TRUE%$#FALSE
Q14508%$#WAP four-disulfide core domain protein 2 (Epididymal secretory protein E4) (Major epididymis-specific protein E4) (Putative protease inhibitor WAP5)%$#WFDC2 HE4 WAP5%$#TRUE%$#FALSE
Q8TF74%$#WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein)%$#WIPF2 WICH WIRE PP10631%$#FALSE%$#TRUE
P47989%$#Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]%$#XDH XDHA%$#TRUE%$#TRUE
Q9NQW7%$#Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)%$#XPNPEP1 XPNPEPL XPNPEPL1%$#TRUE%$#FALSE
P13010%$#X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))%$#XRCC5 G22P2%$#TRUE%$#FALSE
P12956%$#X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6)%$#XRCC6 G22P1%$#TRUE%$#FALSE
Q86Y38%$#Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I)%$#XYLT1 XT1%$#FALSE%$#TRUE
P54577%$#Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]%$#YARS%$#TRUE%$#FALSE
P67809%$#Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1)%$#YBX1 NSEP1 YB1%$#TRUE%$#TRUE
P07947%$#Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes)%$#YES1 YES%$#TRUE%$#FALSE
O15498%$#Synaptobrevin homolog YKT6 (EC 2.3.1.-)%$#YKT6%$#TRUE%$#TRUE
P31946%$#14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]%$#YWHAB%$#TRUE%$#FALSE
P62258%$#14-3-3 protein epsilon (14-3-3E)%$#YWHAE%$#TRUE%$#TRUE
P61981%$#14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]%$#YWHAG%$#TRUE%$#FALSE
Q04917%$#14-3-3 protein eta (Protein AS1)%$#YWHAH YWHA1%$#TRUE%$#FALSE
P27348%$#14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)%$#YWHAQ%$#TRUE%$#FALSE
P63104%$#14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)%$#YWHAZ%$#TRUE%$#FALSE
Q5W0Z9%$#Palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 20) (DHHC-20)%$#ZDHHC20%$#TRUE%$#FALSE
Q96DA0%$#Zymogen granule protein 16 homolog B%$#ZG16B UNQ773/PRO1567%$#TRUE%$#FALSE
Q15942%$#Zyxin (Zyxin-2)%$#ZYX%$#FALSE%$#TRUE
P0DOX2%$#Immunoglobulin alpha-2 heavy chain (Immunoglobulin alpha-2 heavy chain BUT)%$#NA%$#TRUE%$#FALSE
P0DOX3%$#Immunoglobulin delta heavy chain (Immunoglobulin delta heavy chain WAH)%$#NA%$#TRUE%$#FALSE
P0DOX8%$#Immunoglobulin lambda-1 light chain (Immunoglobulin lambda-1 light chain MCG)%$#NA%$#TRUE%$#FALSE
P0DOX4%$#Immunoglobulin epsilon heavy chain (Immunoglobulin epsilon heavy chain ND)%$#NA%$#TRUE%$#FALSE
P0DOX5%$#Immunoglobulin gamma-1 heavy chain (Immunoglobulin gamma-1 heavy chain NIE)%$#NA%$#TRUE%$#FALSE
P0DOX7%$#Immunoglobulin kappa light chain (Immunoglobulin kappa light chain EU)%$#NA%$#TRUE%$#FALSE
Loading...
Loading...
Loading...
Zoom in to select expression profiles for the peptides in that area
Loading...